06-06-17: A696-04: [4] T.84.4-86.5: NCIS Iatrogenic AIDS Docs & AIDS Corr

Page 1

J 111

G.P -S. 003-0296

DEKBLAD VIR APPELSAKE COVERING SHEET FOR APPEAL CASES ,~,

Aan

die Griffiar:

HOOGGEREGSHOF

To the Registrar:

PRNAA TSAK X9020 KAAPSTAD

tk5f~ GEORGE

Van die Court: From die theKlerk Clerkvan of the Trial Cenlre: Verhoorsetel:

I

GEORGE

'Case No . Saak No.

.,v~ GSH 2a"'~

Appeal.No. Appitl No.

"Setel van Streeklanddros:

"App81No..

GEORGE

, Seat of Regional Magistrate:

Appeal No.

Date of sentence:.

NEE

Is 'n Regtersartiflkaat toegestaan? Has a Judges' certificalebeen granted?

tVerskyn Ct Maak 'n X in toepaslike

(t Indicate applicable

blok)

"

block with an X)

.

Naam van appetlant(e)

tin

in persoon

hegtenis

Appears

·'In·

~BA .."Qff.N..$.rQ.N1=.""""""""""""h""''''''''''''''''''''''''''''

Fine

On'

Ander

paid

bail

Other

~

X

'

)(

X

.

:

,

:

4

,

,..............•........•.........................

L

. ,

, .......•....................................................

~

(2} .....................................................................•........................•...............•.......•..•.......... (3) ....................................................•.............•...•.•..•....••.........••. (4) ..............•. ,.......•.. ,..........................•........

:

:............••...•........••...•..•....•.....•....•.••.•..•..•.

6530

(3) •........................•.............•.................•.......•....•.••.....•.•..•....• (4) ....................•....•.•...........•.....•.....................•.•....•.•..•.

PRIVAATSA

Dales amp

~n;.~-

l~,:,~i _.~•

~ .

, , OfE' HOF_:-tI ...•... _

'.,

GECf/"

,q·ll RK ~

GEOH"'~"" 0: _ •...""('DATE

--_

.

.J

..•

Copy for your information.

2. Een gewaarmerlcte afskrif van ~ie notule is aangeh

L AND

Q!! 0 S

PRIVAATSAKlPRIVATE I One certified copy of the rD'W •.•. .

'

KLE,,!K VAN DIE HOF PRIV.4,AT~~::'-;:-:-

1

',."

2005 - 0 f -

.

.-::..:-::

~URGE

BAG X6537 ;' .... Le::RK OF ("

19

65030

THE

III N

2004

(.

CO'"":·QJ·f..I ..·.•.•........•.•................................', SA f.:.2~ ......•..•.•....... 11=

nie by verhoorsetel

~estasioneer a trial centre.

MAGISTRATE

Klerk van die Hof

Clerk of the Court

Comp ~te if Regional GEdRGE: Maaistrate 6'530" is nol stationed

• Voltoo indien Streeklanddros

.

X6537

-

_ Q

.

K~'kvandieHof ,ClerkoftheCourt

..• ne: (.;OU~T-. ,., I .

Oat mstempel Da e stamp

,,£~

-

f-

1. Afskrif vir u inligting.

.

; ; .

.

.. " •.••...•.......•

\Gl 66J()

Die Hoofklerk v 1- .••• ,- ..JV' ,. • eraal The Chief Clerk to the Altamey.G~~ral._

.1"B.II!.JI!!.!$.!!/5){I!.QP.L .. ~.~.~~.:.~.~'..~~~~

,;

G X653 7

2005 -01- 1 9 _

,.•.....•................................

:

..

!.-:::-~

. .

IfJt>,••. ",..",'\1 --

re.enclo.

3.

.•

~..•.......• ~.•.•.....•............•....•........................•......•.....•....•..........•...

:

:.•.••. K·•..

J'

- 9 JUN 2004

Oatums ~mpel

.

,•.•..•..•......... ,....•..•.........•..•..•....•. ,.....•.....•.....................•

Dieao~spronklikenotuleen ". i ;-The anginal r ~~ ..••....A .. -I\o.~.f:).R .. ~K.iPRIVATe BAG X6 T 7 !- '"" 1'1 'i7>J

O.

,

~

,............................•................

,,-~

.

,•..••.•.•........•.•..•..•.•.••.....•......•..•....................•..•.......•.•..•............•...............•..•...............

~~~r~: f~~~~~~f~~~s:~~~~).: ~~r::~we.Die"ste Gegrge ,..: ; ,

.

,

~~~:::~~~1~~~~~~&~~~ft~~: ~.~~~

.~

borg

Ja Nee Ja Nee Ja Nee Ja Nee Ves No Yes No Yes No Uitgestel Deferred Yes No

3

~

toP

betaal'

,

2

I

tBoete

inperson custody

Name of appellantCs)

(2)

16/04

'5 ~4"2004

Datum van vonnis:

1

16/04

is nie ..


hepatitis B \'accine were produced by these agencies and then simultaneously tc~ted in New York City on \1av men. Willowbrook Slate School mentally retarded children, on Statcn Island.' :>;)'. -a~d B lacks in Central Africa. The live hepatitis B viruses used to make these vaccines were cxiracted fro'm the contaminated chimpanzees and rhesus monkeys. and then administered to these human subjects. along with all the other live viral contaminants these animals were infected with. including, but not limited to the herpes· type \·iruses. including simian .:ytomegalovirus, Epstein·Barr virus, and herpes B virus all scientifically associated with chronic fatigue which, may I remand you, appeared on the planet at precisely the same time as the AIDS epidemic). Other viruses such as foamy retro\'iruse~ containing theAIDS·linked enzyme reverse transcriptase was also present in these animals. Additionally. most of the human subjects who re· ceived these infectious agents. and whose blood was later taken to make the suspected hepatitis B \accines. had. apI'roximately a decade earlier. received Salk or Sabin polio vaccines contaminated with SV JO. and Jpin. other common monkey kidney cell viral contaminants. This. of course. confounds my thesis. bu't significantly increased the like· lihood that HI',' J:'rogenitor ,'iruses cauld ha,'e recombined to form HIV as well as SIV relati\'es-all a direct result of slcJ:'py scientific methods and contaminated live viral vaccines,

"I,

i

I:. '1!

f

;i

I

I,

i,

,I! I ,I

:1 ' ' "

'1

-

C

Q ~

:-'Iy thesis e.xplains the ma.ior scientiiic facts concerning the evolution of HIV i,nclud· ing: I) the earliest con finned isolaticn oi HI\'. contrary to media headlines and popular belief. dates back only to 1976 as reponed by Gerald Myers in Jay Levy's recently published te:uoock ne Re:rol'iridae: 21 by 1968 there were apparently HIV progeni· tors causing AIDS·like illnesses circulating in' the US as reported by Witte, et al.; 3) the closest relati\ e 10 HI\'·! is the Sf\' from the chimpanzee; 4) the SIVs were discov. ered after HIV: 51 SIV from the mac3que monkey. identical to HIV·2 found to be a laboratory contaminanL was not found in wild monkeys. only Senegalese female prostitutes. who because of their high risk trade. likely received contaminated hepatitis B ,'accines during the 1970$. I How. other than through contaminated vaccines, could scores of these women ha\'e picked up a research laboratory monkey virus contami~ 'nan!"?): 61 the e\'olution of se\'eral 5ubtypes of HIV around the planet by 1975, as de· , tailed in :-''''ers' 5 "Bi!! Bang" theof'·. coincides with the 1974 administration of the four subtypes of hepatitis -B \'ac-cine in '\arious pans of the world including New York City and Central Africa by Hilleman's four tearns: 7) the mutational frequency of HIV is consistent with that of a new virus: 3 Ithe fact that HIV is associated with severe immu. nosuppression. and high mortality and morbidity. is also most consistent with a new virus requiring evolution to establish homeostasis in its new human host; 9) the muta· tional frequency range of Hf\'. again according to :-'Iyers (personal communication) e.xceeds that of anything natural. thus strongly suggesting an iatrogenic origin; 10) the unique epidemiology of AIDS in which the highest HIV seroprevalence rates exist in the e.xact regions of the world and populations wherein the hepatitis B vaccine was tested. namely :'\ew York City. CentrJI Africa. and particularly in homosexuai men, intravenous drug users. prisoners. and people of African decent, that is, people com· monly used in vac::ine trials: I I) ~Iaurice Hilleman's 1986 admission that his team at Merck had brought the AIDS virus into :>;01111 America in contaminated African green monkeys. again supplied by Litton: I:: I that the epidemic broke out the decade follow· ing the 19605 wherein major ad\'ances in genetic biotechnology were made and wherein ceIU\'irus cloning procedures e,'(plc<:led: 13) that contrary to popular belief and misinformation. sufficient homology e.xists between HIV and common polio vaccine viral contaminants. and viruses likely to have contaminated Litton laboratory animals and cell cultures at the time the earliest hepatitis B vaccines were produced, to advance this

i

I thesis ..and last but_not least. I.t I Ihat scient~SIS including Dr. Ro?ert GaIlo and others) " who a<J\anced fartclched notions of the .-\tncan green monker 'c:ory of HTLV-I and t despite their sophisticated knowledge of the NCI's "SI' .1 Virus Cancer Pro· .1 .11

gram" in which viral recombinants and related vaccines were prOlluced, h;I\'c 1'11\ 11"1·;1\ incriminated themselves. A discussion or substantial selr-incriminating e\'idcl1u' I' l'rD- . vided on page 498 of Elller/?illg liimses: AIDS & Elm/a. That vir1u,ll1y no alll'IIIII'11h;\~ been paid by your organization, the NC!. as well as other AIDS investigalor". I·' Ihc iatrogenic theory of AIDS, is highly suspicious if not criminal. On related notes, that leading AIDS investigators and puhlic health olTlcials IWl' ":1\11, tinued to downplay the neet.! 10 determine HIV's origin, 'and possible continucd "1'll'ad through.contaminated vaccines, !lies iri the face or ethical public health pr;lcli,'l" ;lI1d preventatiye medicine. Moreover. you may not know that on February ,I X. I')()7 .Llll11H\' Nunnally of your Office of Communications scnt Gil10 Montesi and r,'likc Car,i,' r,'\l11 WXTK Radio on Cape Cod an oflicialtransmittal from your office that slales.,·'lhc " irus that causes AIDS. is not a man-made virus al1d dit.! not oril!il1ate in lahnraloric'; , , , It i~ a human virus that e~olved naturally over time, as niher viruses have," Who ,ltllhl'll/Cd her to communicate such misinformation? She references only the "World Gon!" I Ill':' cIopedia which was wriUen by one of our experts." as her dclinitive source. Thi·, IS ;\ sham-an absolute insult to medical intelligence, Why should I and the gene"III',iI,lic trust you, or the organization you represent. in lighl of suchunfoundcu. bia~L'l1.al1d misleading communications? ' Finally, did I hear correctly that Dr. Gallo is. once again, under investigatioli J"", ,.'il'l1tific misconduct,or fraud? Having challenged Dr. Gallo at the XI Il1ternational C"I1Ie,· ence on AIDS in Vancouver, regarding his role in the development of numerous illllllllllC system ravaging viruses while NCI project onicer, oversecingLittol1's NIl-! C('"I';Il" 712025-"Investigation of Viral Carcinogenesis in Primates"-I have reviewed hi, majllr objections to my thesis which, by tlie way, arc discredited by his and his NIl-! 11I1'I1!"I" earlier scientific contributions. I am enclo$ing a copy or a letter I sent to Dr. (;;111.' "11 October 28,1996, wherein I reJ"ute his misleading claims. This transmillaJ It,IIII\'.l'l1 a lengthy interview he provided me wherein he acknowledged my general thesis i, l'lau. sible. Most importantly, he stated that he might be able to Icnd additional in form,1I j, 111in support of the accidental theory on the origin of AIDS. I still patiently await Ihis illfor· mation. In conclusion, I gladly accept your invitation to discuss these mutual COl1ccrn~, hut I don't want to waste your time and mine playing lip service to the issues, II'you "r "ther CDC officials are wil1ing to critically examine the facts. take a $Iand for COll1mllll '.CI1SC and scientific integrity. il1c1uding a willingness to examine lhe CDC's apparcnt I','k in developing (along with Hil1cman, Purcell et al.) the vaccine that most plausihly 1'" 'lI~ht AIDS to the world, then I will be happy to schedule a visit to Atlanta to meet \\ilh :'011. If not, it's possible I'll see you in heaven or, with God's grace. and the supp"rI "J" Ihc American people, beforc a Congressional investigating committee.

r

Sincerely yours,

::$-<-'17~"':'(../;

y II

J"'~'

').

Leonard G. Horowitz, D.M.D., M.A., M.P.H. Prcsideni, Tetrahedron Incorporated a nonprofit educational corporation Rockport, Massachusetts 01966 Telephone: 508·546-6586 • URL# htlp:l/www.Tetrahedron,org E·mail: tctra@tetrahedr

l_'g

,

~

.__ C'.,.'41


. TIIE l\1YSIERIOUS ORIGIN OF HIV: REVIEWING'I1IE NKfURAJ..i, . IATROGENIC, AND GENOCIDAI..i TI-IEORillS OF AIDS Horowitz. Leonard G, *Strecker R, Cantwell A, Yid D, and Grossman G. Tetrahedron, Inc., a nonprofit educMional corporation, Rockport, MA 0 966, U.S.A J

Issue: Two-thirds of African Americans recently surveyed hC/ieve thcAIDS epidemic may he genocide. Such beliefs Illil)' impair hcallh service utilization and preventive behaviors. Moreover, reconci Iing the origin of HI V is addit ionally import;1111 for I) sociological reasons-victims of AIDS should not he blamed for starting the epidemic, 2) scientific re~lsOnS-nc\\' events precipilal if)l~ therapies might be developed from a better understanding of HIV's origin; and 3) ethical reasons-the the epidemic should never be a1l0wed to happen again .. <::JI

-I

Project: In an effort to shed light on this most mysterious and controversial subject, a review of the lilcralurcwas iniliakd to determine the most plausible origin of HIV -I. During a two year period, more than 2,500 documenls were collected (Ill! I critica1ly analyzed. This analysis included all natural, iatrogenic, and genocidallheories of AIDS's origin as previously presented in the scientific literature and lay Illedia. Uesults: The lay media appears to he an imporlant factor in Ihe devclopmenl of hel iefs regarding the origin or A I I):;. Numerous puhlications and hroadcasts on this suhject were found, most advancing the nalural-. African green monkey theory of AIDS's origin. The scientific literature, however, provided no dircct evidence for HIV'snatural evolution [rulli monkey to man, only circumstantial evidence. Allernativcly, a growing hody of evidence in the scientific litcra(I"\~ suggested an iatrogenic origin of AIDS. Specifically, the possihil ily that HIV -I and HIV -2 evolved during early lahoralof',' investigations and vaccine trials isof growing inlcrest. Evidence supporting the genocidallhcory of AfDS which appe(lwd 1n numerous lay puhlications, and rarely, in esteemcd periodicals, was cle拢lrly circumstantial, alheit disconcerting. Lessons Learned: The spcculation that HIV naturally evolved to he horizonlally transmilled from the African gn'l'll . monkey to man must be seriously questioned. Altcrnatively, more c()Jlsideration should he given to a growing hody (}r scientific evidence supporling an iatrogenic orig.in. Moreover, the gcnocidalthc()ry or AIDS could not he ruled out. The above abslract appeared in (he scienlific proceedings book as abstract ff 03678 presented on July 10, 1996 during the sodalsciences defended by lead author Or. Leonard . G.Horowitz. The American news meda failed 10 cover ttle presentation despile mulliple invilafions .... . . .

(

\

session of Ihe conference. The paper v:路:s

(


Fig. 1.3. Litton Bionetics Contract Report to Investigate Viral 'Carcinogenesis in Primates' by DevelopinglDV / AIDS-like ("Type-C" RNA Retro-)Viruses 1962-1972 ,

,

tIl.UNr,:n,cs RESEARCH LA.BORATORIES jNC.-_ Investigations

~:

Contractor's

(NIH-7~-2025)

or Viral Carcinogenesis

Project Directors:

ProJec~ Officers, (NCI):

in Primates

Dr. John Landon Dr. David Valer,io Dr. Robert Ting

Dr. Roy Kinard Dr. Jack Cruber Dr. 'Robert GaJ.lo

ObJectives: (I) Evaluation or long-term oncogenic erfects of'human and animal vir~ inocula in primates of various species, especially newborn macaques; (2) maintenance of monkey breeding colonies and laboratories necessary ror inoculation, care and monitoring o!'monkeys; and (3) biochemical studies of transfer RNA under conditions of neoplastic transformatiOn and studies on the signif'icanceo!' RNA-dependent DNA polymerase in human leukcmic tissues. Major findings: This contractor continues to produce over 300 excellent neW"born monkeys per year. This is made possible by diligent at,tention to reproductive physiological states of female and male breeders. Semen evaluation. artifical insemination. vaginal cytology and ovulatory drugs are used or tried as needed. Inoculat.eO and cont.rol in!'ants are hand-fed and kept in modiried germ-free isolators. They are removed from isolators at about 8 weeks of age and placed in!'iitered air cages for mont.hs or years of observation. The ho~ding area no~ contains approximately 1200 aniQals up to 5 years old. Approximatel~ 300 are cu.l.led, every year Bt.,a. rate of about 25 per month. This is ,necessary to make room for young ani~als inocula~ed vith nev,or improved virus preparat ions. During U,e past year macaques vere inocul.ated at birth 'or .L!i. utero vith the Ma.son-priz.ermonkey mammary virus. Epstein-Barr virus, Herpesvirus sa.imiri, and Marek's disease virus. EB virus was given with immunostiQulation ~~d immunosuppression (ALS. prednisone. imuran). Australia ant.igen was 'given 'to nevborn African green monkeys. The breeding and holding colonies ~ere surveyed for a.ntibody to EBV. All breeders vere positive and their offspring contain ma.ternal antibody for several months. Colony-born of~spring that have lost maternal antibody and are sero-negative will be surveyed periodically !'or conversion to the EB positive state. An RNA-de?endent DNA pol~erase siQilar to that associat.ed with RNA t.umor viruses was detected in human leukemic cells but not in normal cells stimulat by phyt.ohemagglut'inin. The enzyme was isolated, purified and concentrated 200-foid, making possible its fu:ther characterization and study inrela.tion to the leukemic ,process in man., ' Si~nificance to Biomedical Research and to the Pro~am of the Institute: Inasmuch as tests for the bio~ogical activity of candidate human viruses will not be tested in the human species, it is imperative that another system be'developed for these deter:nina.tions and, subsequently for the eyaluation of vaccines or other measures of control. The, close phylogenetic relationship of" the lover primates to ma.n Justiries utilization of these animals for these purposes. Further study of altered transfer RNA and polymerase enzymes would determine their significance in neoplastic change and prOVide a basis for selection of therapeutic agents. ' Prouosed Course: Continuation vith increased emphasis on monitoring and intensive care o!' inoculat.ed animals t.o determine if active infection occurs. effects of infection, and degree of i~~unosuppres9ion ~hen used. ~urther studies of human neoplasms at a mo~ecular level ~ill continue. Da.te C'ontract Initiated: S/)ur;"" _ \. _

••••••.•

\:C!

,FeIJruliry2.2.1962.

-.;t'lt't' Tili' ';,,",.-it! ~ ••.•• 4••.•• : ••• I.

the AssociatcScicntdic Washington. D. c.:

u.

r'i"T\ 'I •••.

C /"I''''

'LT

["·,'11"/"(11/'· ' •.••••.,.

I.

[>U)(Tj't'\\ ~••••••••

_

p,"),}I" ~ . '\"'!

I

=.\'

()r';i'"

\..

~ 4

'"" -_

"I' \.

Directorr·cr \·ir~l! Onco!l)gy (O:\SO\'OL J, 8, [\lolon\..')'. EeL S. Go\';:rnmcnt Printing Ut"tic(', I (no. p.llq.-05


.>

Higher

Forms o/Killing:

~V(1J.1(lre

"lVOIl-lethaf"

, Fig.ill.I. Congressional Record of CIA Biologi.·caI Weapons Project MKNAOMI As Part· of ';.Top Secret Mind Control Project MKULTRA.~ .' PROJEcrMlULTRA,THE RESEARCHUf

CIA'S PROGW

BEHAVIORAL

OF·

MODIFICATION

JOINT HEARING _DO ••. TS~

SELECT· COMMITTEE' ON INTELLIGENCE .&JfD '%'1UI

SUBOOMMITrEE ON HEALTH AND SCIENTIFICRESEABCH

COMMITrEE ON HUMAN RESOURCES UNITED STATES SENATE NINETY -FThJH· CONGRESS' "UUT SIIS810N ~UQU8T •• 1871'

~tad

for Ut. ~

ot ~.

aAd Comm1tt..-

hi~

C41DmJu_

ota

IDtal~

OQBumaA Raoan:a

~o 9J'.)~

'W;... ~"1 ':.~'!t ~~rl

..'\LD~~g~ Q.( ~4iD4Qt.a. W .•.•Io:.:o~o.a. D.C ..

0.3.

:0404

Q.o"Qr-..a"o,1,

Pt1~U.;J.!t C~

~I~.~.··· IH_s

!;'>::

~: ~r.:

No. CC:l...Q'T~':'1-"


••

.. >

Death in the Air

lodf Fig. 11.1. MKNAOMIand MKULTRA Cont. that no". damage wasinterroga.tions done to individuals. who& volunteer for the expericombination of, sodium, ments. Overseas utilizing and hypnosis after fhysica1 and psychiatric examinations of the subjects were also part 0 ARTICHOKE. ' . '

pentothal

Tbe Office of Scientific Im.elligence (OS1), which studied ecientific initiaJly ledfor BL'OE'BIRDI ARTICHOKE advanees hoet.i1e powe~, efforts. Inby1952, ovei-all, responsibility ARTICHOKE :wu trans-

ferred from OS1 to theOffice Inspection and SecuritJOftice (1&80), Servp~ deee!!Or to the present of Security. The CIA's Technical , ices and Medical Staffs were to be called upon a.s needed; OSI would retain liaison function with other government agencies.' The change in .leadership from an intelligen~ unit to an operating unit apparently reflected a change in emphasis; from the study of actions by hostile ~trers to the use, both for offerulive and defensive purposes, of speCIal interrogation techniques-primarily hypnosis and troth

serums. Re{>rMenta.tivesfrom each Agency unit involved in ARTICHOKE met, a.lmost monthly 00 dJ~U9l! thelr progress. Th~ discussions in-

,elude?- the p!D.~ing of ove~a8 interrogations' as well &8, further expenmentatlon In tne U.S. ' ',' Informa.tion •.bout ~rojecl ARTICHOKE .fter the fall of 1953 'is SC8.ree.The CIA ms.mtainstMt the project ended in 1956, but evi· dence SU~ that Office of Security a.nd Office of ].!edicn.l Sen"ices use of "s~ial interrogation" ~hniques continued for !evera.lyca~ thereAfter.

'

3. !JKNAOMI MKNAOMI wu another Im.jor CIA pro'm.m in this 1'.re&. In 1967, the CIA summ&riud the purposes, of MKN AO~rr : ( a.) To provide for •. covert support. hue to meet. c1l.ndeStine opemtiona.1 requiremew. (b) To stockpHe Mverely incapacitating •.nd lethal ma.·

~na.1s for the speomc use of TSD [Technical

/..--:..-

,

Services Di-

~~~.' (c) 'To ms.inta.in in operstional

. rea.diness special &.ndunique items for the dissemina.tionof' biological a.nd chemical ma-

uriaIs.'

",

(d) To provide for the required surveillance, teetin£, up· gradin~ and eva.lm.tion of materials and ~ms i.n.order to IMU~ ab;nce of defecta and complete pre<hctablhty of re'suIts to be e%pected ,under operatlona.l, conditions.' , Under tn ~ment reached with the Anny in 1~52. the RDeda.l Opera.tiOM Division (SOD) at Fort Detrick was to assist CIA in developing, testing, &nd mtlint&ining biological agents s.nd delivery , • 1Iemorndum trom Ro~rt 'l'aTtor. OIDDIP tn th~ ANtstant DeputT (ID~Ion and 8eeurlty) and Chiet of the 1\tedlcal 8tatr. !1221S2. • Memorandum from H. !darshal1 Cbad,..,,11.APlltant nt~or. 8clM'lt~e Int~;" llr-en(."@.to the Depvty ~~1P1.n9' (nnp) wp,.niet't UTICBOKE," 8/.!9/S2. • "Pronea Reperl., Project ARTICHOKE." 11121!!3. ' '}J~~D~nm from Cble!. TSDlBlo}oc1cal Bra~~ t'() Chi~!. ~SD ""V'KNAOMI: T~!'J~!n~. ()hi~h'~s. Itnr1 A~m1"l1l"}oo""'"'Dh," HV'81'r.'. D. 1. T;"'>"t" :. ~lie:, d~?tion ot ~1CNAO~I £nd tbe !'~i~tiotlc:d~ ~ee.n CIA ud s..:JD. ~ ~ ~ t!.

184

I

I I

i


l1ig/ler Forms oIKilfillg:

"NolI·lefhal"

r.\ ()

m7llc/re

1.----Fig. 11.2. Declassified U.S. Army Chemical Corps Document Showing Genetic Engineering 1)f Fungi with Viral Nucleic Acids by 1962

SECRET WJ!'Horch.on.ne~ tltkeltshl

SfCRky

S~~.

lroplClI

OF MAJOR EVENTS

SUMMARY

disuses. artit

.rlfort

d!nctrd

Whropod-b.t.n.)

.1 Incru •• d Ilral·h,M

Army

cU)

•• nt (Of tHt

t~) In R.t:

FISCA~ YEARS- f96,;, - W62:'·

:'.

'Aa:€$. '.'1.11#1 ..••. c:U,~tii£lU~ . ~:r..rs~

b_

.'

If

A •••.

~IIIo1F

J U-N E r9'1Y2 ON:

Co.p~ J/i!iforical

e"..".mf.~ C'llterj

'\

rJIII!ILJllv RrQUIR!J)

1laI. ItI'UASABUI '1!!IfII(/'f" JtOj(£

!J

'110 "OIU'ION KATlOI!M.B AtmlOIIITY or OCCHLO

H.d2

R'>~:~:;;~: £reRfl ~ 5..E0RIT~

••

. 12

,

C~

bltf

lepto.plra.Io,

lhe vlrUt 01, al ••••• I\.-

de••onltrtlod .• 1hll.te""'plloh-

dlfflcultl"

In 1he palh of luture dlY.lop-

•.nd.lungtl

.g,,,tl,

Ind cry~toeocca.l,

••• .!ork on.hcll!ul.

.n!~rlch,

thl tlu!aU" rllch.d

arg.nll,,!_

\.h. hbortl>r-1:.

. In Ig.nt !h,ich..!!!!, !>!!n th'

••ont J.o-"-,~

~_p'r

01 d...-ylr.g•••lh~<.!!.

pro •• " u.ureh,

to lhlt ®n'

ptrtlculnly

In th ••.•• lu.Uon

prebl ••• or prOYldlnq .doqu.h

ttvlty

'90nt r ••••lnl to b•• 0Ivt<!.26

.of IM lIost,atrlklng

~•••• reh hlr.g

r.e!~fI

~\

••••• ·••••nt or' hum.n .u.eoptl-

IIn".o.r

,Inquiry In.th.

Corp' pr,09r~~

dan. by the 61<>1-eqle.1i.bofll·orlll

.!!.nd.rI>'lng the Inhet IvUy or nlcro'orq."l.n.~

pp~lI",ffoll

st·P.

1!!.bJ.•~t-'lllllOr .• or 10•• cancern .ta .th •. Corpl rar ••any Y'''I,

~~Ic

••o:e 1501.!td I,em virus ••.

!,n...l.ho90~'Uc

tluehlt ·n:.l

.dd.

.lhlOp!'

.•~~ "et~rI

e.·rrylr.q Inr.eal Ir.dudr.~ n~

2~ GoOdl"" !nt"v,

"

!!J-iJ!-tJ

~,fA~

01 • traHtr ~nonn I~nl,

•••• tute.nlully

one 01 tho.pr.lnclp.1

J>lJtopl~''''lh,

blllty

.Ko:"'MJ!:J \rIICI.AISI'11D n~ Si7AJ\.\rl:> FRO, . CI.ASSlflC ~

A ••aJor

ol ..th •. dry,ag.nl ..through .d~lIlon

thl rill •• al b.th.hl

But th. crutlol

Officr!

1Wis

l

I"!

MarJland

.

H!:~I)J.

«':I.oo./It

rE~~~~~

V,S. A rm..r.€~£al A rmy

1>;11

.ttudle,L!.rL

.gont.2~

lcrttn!ng.llt9

•...•.1

.o·et! ad .ubj!

•••• bolng o••rhu!.t<!.

In the d.v.lorcent

~lIOIInt.of .ono.adluN gluh~.h

ChemicaICorp.~

prtv.hn.L\..IL - 62, -Ith •••Jor•

knonled~ of lhhl

01 .ndttvor

•.!!.!ttbllh.tlon

lIont .1I11!n.t.d

States

vlrUI dlseues

.!)d,

v!rulu • .The IInpQrhnc'!j)1 .pIM",lolo~ltll

••lth this 'uu

mltttcal!L-!!.h

PROBLEMS

on viral

tlQJ! ••lthln the ttrten\.fot pr ••••.. I,. n-1961

lPrwtrd ••••• thirvtd

and

United

A ~hole u"'.!. of uotlt

il..,'."

Jonnectlan

.• gtnl. "".t.ndtd,to.toncenttJl'

j (CO.Ples

16 Frb 62.

26 (J) 62, p 2••

.illJ.

(.) Ttu":!'!

FT"9~~ R....u.•.& An.IYII.,

Slo l.b.,

J.n - 'IIIn

SECRET P~G=.--!l:!-0F ~r~S3

.j f c8R.s.i79\·&2

i

. ccrl __

t_,_or ~O)rt=S

f

OC'ftt. \j C Hi: //t::J..?;;'

i

I!

1~6

I ,~_ .. ·f\·

::"·i·: .. .

I ~:7


____

•••••••••••••••••••••

J..A'" I

_

--Fig. 11.2. .Chemical Corps Document. Continued_ . ' .. .

CONFID£NTIAl. ~mbin.ti~ns Icid.

~m

,ienetlcs

of genetic different

were dso

sources

in

.htnth,

~nt

the ~lxture

of infectious

undert._en 1n FY 1962.

with the

.illl o'f

nuc1el~.

Sludits of bact~ll~.

transferring

genetic,

d.e{eroi:-.

27 Qr~.anism ..to _~.n£..t.h~~

1'fiSrr.c~d

V .ge~ts

E41RJ

throuQh

.,re

progress

!l!.n}Lff~.:m-.J.)'~ ~

alUaI for C.nd

fictors

ur;"

detection ,1.r~-~

1n

ih. third qu.rter

Iccepte~ bt the Army

1962,

of FY

fOt liQlted ";,. ,Or

'i

pro~ctlon,

thereby

MiHtiryReq-liac:ent

.u:c;n.l~: •.lu""

for

• t6I't!': :e~ctio~ on ~ treatea • lKX1i{ied vH'slon

7ut

Board

limite<l

t.ests

it le••t a portLo~_of

fulfil1~n~

of the euHer (to

The E41RJ, "hlc~

Sitisfy

lIIodel

In

aper.tts

t!'-.:ough

audio s1gnl1, h ~8

wet tape end .color-actuated, -

of the E41Rl dlscusse<:l

procurement

th~ existing Cu.11tetlv,

in the FY 1960 Annual Sumuy.

F'(

an lc..1\edlate

1%1.

ApprOval

operational

ofth.

-

11':lIIfo:

requlrealtnt

for 4CO

29

a1 arms)

came 1n J .nUiry

- (C) An .ctive

.(~.(tR) ~nc;.

of 1962.

prc.gram

t~ard

the develop;lIent

of • long

pit.h

,ysteJa for erei 6c.nnlng .lar:ns reached the contracting of FY 1'62.

Th""E4Q. LD?J..ffi system,

ulected

Infr.-r~ ,t..ge CltO:'

for devtlc:~~cnt,

"u

t.he

27 (1) GoC':H:-" ino:e:v, _Sio L&bs,

O~t

- Dec

le- Feb 6:.

(:2) iechni~al

hogrc:;

Rev:ew

1.

,I..:lall~l.s,

61, pP 17 --18.

26

29 cere Ite~s 3934,26

Dec 61;

i~j

395C, 23 Jan 62 ••

;I

188


1001 Ag. 13.2~.National

Security Secret Memorandum J:.

206.,:

CO~:!O~'"7r;c

U j~ \,.'~.t-;,,; •• J~J

~.r:::A7=ON$ OF WO~"!~! FCrL~::C~GRC~~~ rep- tJ. 5" ~!CiJR!:~ )..'1DC\'!...-:..5!.\5 !."-:.!:J~:-5

.- .

C,).,Ssu:ti:) !'t Ear::)' c. Jlanc)' f Ul . SO!JtC!10 C!N!~ ~tC~5!r:CA1:CN SC~~-! er IXIql"!jVt 01t:)!R lH52 ).t.r:O!"';'~:~'! CO";;CJl..\:~ ).~

.1'.10 ~

O"N

1m't~V.1.l.S )..'tD tta.:.sS!TIU

tta:.... .3t1.

31 f 13 a 0 :

ctClASS!HE!J

~

to. /~~

.-----~--~ . .J"1

;:.'''fI ~~

:... ....1~ "<"', D.-, ··k ....:·.; .., ....." ~"".I·',' : .. ,~. r·.. - "~~.,~.u..1.~~ L 1..." ~ •'\· 1'-1"\.1 •• t,,\,1LI •.••••.•_, _~ .• ;-"'.tL ...:.__ u;.. Kissin~er. this document streJ.l\.:::::;ises .C.S .. >~Citi()nCi Sc;cur;t:- "Jip]Ot11<lLic" responses to Third World popubtion thelL stood in the WCiy of accessing natural resources for globalists' corporate interests.

rL..

-

·1 •..•·~1.}.1·..·

••.••..•_ ...•• ..I

~

'..~ .•..: ...;-,.;.....; '1r"';; :-- ..""":''''':"d ~: "'fLIL ••_lt ~",~_V.j.JI,)~"t,l •.••.••.


'L

r.,

'accinativtl.:i for .

'.•

,,

'-

'Fig.14.1~D& Sat~her:sl.:e.tter_to .Dr.lJo~o..witz. Concerniligthe ~ ~,' .. Triggering of AIDS via Vac~~.e~' '

,

'

'.

~~l.. ~ . ~

'

,

,:-

DEPART\It." Of HEAlTH' HeM",

'

,ER'ICES

Ailai1tJ GA 30333

~~AY 22

Lecr:a::-dG. Ec~owitz, 7e:rahedron

Bex

D:.

Read

Massachuset:s

ter your

you

on February

and

Prevention

cor.tamination

CDC'believes public

0:965

Hor:witz:

h k you T,a;;,

your

14.2.:1.

402

~Rockpcr:,

~ear

~I.A"

?llblishing Group

20 Druolin P.O.

D.M.D.,

iSS7

1etter

21 to meet

wi:h

{CDC) officials and other

that

public

to discuss heal:h

however,

C

.chis issue

would

issue

is· the

believe

not

serve

:0

Control

of·vaccine

foundation

the a::egaticr.s

therefore, likely

the

exter.aea

Disease

issues.

do not appear' co be based

bformaticn.

0

the Centers

scientific' evicence

:;ealth policies;

letter

"h ' " a:lon cor.cern:Jg t.e ~nv:

rer so~r.d

contai:ted :liic~i::·

on credible,

evidence-based

that a meet:rrg to disC'JSS

a usef~l

purpose.

Sirrcere~y,

David Sa:::r.er

I I

... ~., '4 :';

I

Ph •.•• &,~

T'

.

ahu\'~ k:~~~r hy CO ()l' [)ir~ctur. [)a\"iJ Virllses: ~dtch~r. .·1!DS ~,\~~ (:ooinr.IJ~J.:J i'n rt.:~,piH1SI.: III ~!1L: it.:t!.~~· )~:I~ ~ \ °TlIt: by Or. HorO\~·ilz. rcprinreJ in Emel::;ing & Ehli/"-.\'Uf1/i'1.!, ,Jccidel/I or IlIfelltiona{J e,'{rbining. anJ Jocumcnting. th~ CDCs roi\: in co-rroJucing the 197.1-1 (J7S hl:ralilis B vaccine thal apfI<m:nlly aiggt.:nxl the AIDS panJemic.


'.ULatli

:rr tli,'

" hccillal

:lir

In ;1n official

NEWS RELEASE

invitation evidence

.R.:~~~~~".~. ·-I-.E\· u

to Illeet,

Foor 1:T::l·.~..!i ..!I~ R~·~.! ..~

In response.

(DC Director Pulls lIn-itation to Discuss Controversial Book on AIDS-linked Vaccines R()cki7cn, \1.-\ Cenler' for Di,ease Cl1ntrol Dire~tor Da\id Satcher. ..:halkn\!ed b\ ,;cienliq~. concemed:1bcut

\ a\~cinatjt'n

ri,k,;.

and Pre\'ention Black leaders.

declined

.15 a ro.;sibie L1utcome 01 cont:1Ininated '\ accines and hi£hh contro\er<ial J('ok Ihat documents

to discuss

.-\ IDS .

with the author of a new the CDC and Food and

a \'accine that might ha\"C Drug ..\Jr~irii>tfati(1n I FD.-\ helped manufacture transmined .-\(DS i\ orIJ\\iJe. The exchang~ between the author of £I/Io:g· J

%

;11? \ ir.l.le5:

.-\IDS iIll,l Ebula-.\'LlTlIre,

.·\CcidclIf or hitel/fiol/a/:'

(Tetra-

hedrcn Publi<hing Gwup. 1997,. Or. leonard Horowitz. a Harvard graduate. indelX'ndent in\'estigatOr. andinlemationally known public hea"li authority, and Or. Satcher. followed a recommendation for a moratorium on \'accine.; '2~ [he \'ation of Islam's He;1lth :'-.Iinister. Dr. Alil11 ~Iuhanlmad, ;1nd a ;;1X'~iallegislati\'e comminee meeting of the\'ational :>'ledical As;;cciatiC'n. represeniing Black physicians of .-\merica. in which the book's main ·the;;i<. and supporti\'e documentation. was considered. All panics ;]gr~ed that growing fea.rs o\'er \':lccine contaminations, and associated hea,lth risks, should be addressed at another meeting pfC\posed, then cancdkd,

by Dr. Satcher.

rapidly

gm\\ ing grass roots coalition.

writing

contingent

Dr. Horowitl..

supr<Jrted

upon

by thousand;;

an official

accepted

of concemeu

citize'ns

Dr. Satcher's

invitation

in\ estigalion

in a

played in "developing the \accine that mo~t plausibly delivered AIDS 10 the world." In hi, !XXlk. t\\O man-made theories ot' AIDS's origin are ad\'anced and !x>ISlered b\' astonishin\l20\'emment documents including :"iational Cancer Instirute rePcrtS sho\\ i;g- how much L'. S. taxpayers spe;t for contracts to de'.elop .lJ1d test immune syslem destroying \'iruses on monkeys and humans .. -\ccC'rding to Or, Horowitz's theory. the CDC. FOr'<.. and ~'erck & Company. a leading \'accine manufacturer. de\'eloped 200.000 human doses 01 a (X'tenrially l:ontaminated experimental hepatitis B vaccine that \\ as given to thOU5ands ot' Ccntral Africans. gay men in :\ew York City. and mentJ.ll: relaf\Jed l:hildren on St:Jten Island. simultaneously in 197..\--perfect

19-5.

:::58

timing

for' the initial

'

outbreak

of .-\!DS

cases

in these

areas

hy

sound

the "COC public

"do not appear

hcalth pplicies."

(P thousands

conllnents

rigorous

\n:re

scicl1lil'ic

Ill'

th:1I s,'i"11111;,' al1d Ih',11I),'

to he h:ised on cn:dihlc,

Or. 11,)("()\vitz reported

truly demanded

hc withdl""1\

believes

C)'i""'h','

or Inle'rn,'I ..1\ '~Il . raise :111" mi,lr':,.1

proor

to

SIII'I"'II il,

public heallh policies," Or. Horowitz said, Ihen the CDC would ai,,, I',' calling for' a Illomtoriulll on virtually ail vaccinations "which. to d:\I,', lack definilive scientific analyses showing positi\'c risk/henefit r:ili," .. In fact., Or, (·Iorowilz wrote Or. Satchel', ami pharll1acel1tic:d ("Ill'

cot

p~ny experts "uon't really know whether vaccil1cs arc harming more people than they arc helping or sa\"ing." Likewise. Dr. Horowitz ljucstioned how much scientific the CDC

anu FDA orficials,

uemandcu

when

their "Illulual

or "illli:'~ e\'id,'IiI,'

consel1l

\\;1'

given tu blood and pharmaceutical inlerests to sllstain the use (,F 111\' contal11inateu clotting factor VIII and blood supplies to the puhli,' h', tween 1983 and 1986," despite the facl that thcse officials prcdicted Ih.·" sands would die as a resull. Furthermore, in 19:)-1. whcn Ihc hcp:nitis /J vaccine

link to the AIDS

epidemic

\vas first advanced

thcn il1\'esli!~:II\'d

by CDC and Merck, Sh;,rp & Dohme collaboralOrs. homoscxualnl~n in New York City were known to be the primary and earliest lest subj,','I' for the suspected

vaccine.

Yet the CDC

omitted

Ihe New York Cil\' ,!::I:

men from their investigation and focllsed only on Denver and S:1I1 1'1':111' cisco populations that had not been imll1unized using Ihe earliest, 111",1 implicated, vaccine lols. "No wonuer your :expert' CDC aUlhors rell1;,i'n,'" Week!.)' Reflort," Or. 1·1or, !\l i I/ •Anonymous' on this Morhidity & Morttllin' chided. "( too would feel ashamed to affix 111Yname 10 such hogus '"t'ience.'"

in

into the role the CDC

1'01'

~ll'Ir,'cid~'

Or. Hp!"Owitz in which

that Or. Satcher's

ing, "If the CDC

(CDC! and citi-

le(\er,IO

i~ the foundalion

el'S, ariu Ihe press,

~llob'll

/i71'

Dr. Salchel" slated

j'lo!"Owitz's allegatiOlis based inr()rlllation.",

D.H~ \1.:::eJ: J:..:n~ 1.... :~Jl.J-

zcn£TCUt:'s

iOlls

Regarding information"

based

Dr. Satcher's inability to see ailY "credihle c\'id,'n,,'· in Dr. Horowitz's writings. Ihe author replicd, "11 h,'

did. he would also see himself and his agency are now fully ex!,,,,,,,!. And since rumorhas it thal Presiuent Clinton is considering Dr.SalChtT for the Surgeon General post. putting on the 'Emperors new clothes' ,nil.' him fine-a Black j-nan who can watch his ")\I'n pcoplc,.<lnd milli'Hl, "F others,

die wilhoUl

seeing an}'lhing,"

Press release issued by Dr. Ilorowitz';n tion helween

chimpanzee

It:asc. neglecled and

,'emher

!')<n, Iss,'

,

hcalQ1

\.

In (DC

Direel"',

Da,id

Sald,er's,

11'1'1' ""

for Ihe Iir__llimc:1 \'~lrt'inl'·lillked l"PIIII.'\'and human AIDS, and Ihe \';rnses assne;,"ed \\'ilh Ihem Till, 1,'·

by mainstremn

pnlilical

respnnse

findings Ihal explained

dismiss:11 orDr.llorowitz's

ncWs

smlrcc~.

•..."hlic:llions including

--2. p,l 35.

Ihe

\\'ns ultimiltely puhlisht'd in s\.·\·t~ltll ;11"'111;111\ \' lfJ1rn.\T"d 1.I'''eT/(1r DO('fOrS (\:. 1'{/(i~ 'I".

.--1I


Proposed Course: It is to supply the necessary needs of the SVCP. BIOIIET:CS RESEA.'!CH LA1\ORATORIES (NIi1-69-2160t :1tle:

Suppor:

Ccntrac:ar'! Prc~ec:

--

c

c::>

\

Services

?(o~ect Officer

(:ICl):

for

Director: Dr.

t:Je Special Dr. George

Date

VIrus

R~bcrt

Cancer

Progrart.

Current

Todare

'''::eo aber:!ve:, tr·ansiorned ce115 containing ic-infeccec v::h SV40. thty nad a lover rate cc:'1, \I!t;,out the genetle; thus, th@ presence i=unIt::_

SV~Q genome were of transformation 'than of SV4Q did no.t confer

Fetal thrncs ce:ls of dogs vere cocultivated ,.rc~~ ~pl'~ :he dog cclls ~~~~~n~ratlon (chr~s~e aoa:79i9 nov being done).

'Jith

cult~res

tranSfOr3dricn i~oc.lated i~:~

oC

i~fected

vith

Ha90n-Pfizer

and caused re~r~ss1ng ~e~~orn rhesu~ ~n~eys.

t~ors

Irradiated human and_transformation

virus vh~n

shoved

evidence

subscquer.tly

Ce:l~lar ~~uni:~ s:udie9 of leuK~ia patients, using lyrnphocyte cytctcxiclty ~~d cytotexi:it? l~hibltlon t~sts, suggest that ccl13 cl s~c~ ~atients pe9se9S le~~ecl~-as90ciate~ antigens and thst ~ syS:eD =~y be·o~eratlve In human and 3ni~al \I!despr.3d a~t!ge~

tunors.

SI~nifica~~~ :~ 3ienedlc~! a~5eJrch and the Program oC the Institute: This c=ntrac: :4bQr~torv ~rovices In opportunity for a 9vstenatic, large-scal~ effort to detect viruses and/or viral antigens 1n human t~r 3acerials (~arcicularly leuke~as and sarcomas), using tissue culture, ~cnolo5ical, biochemical and E~ techniques. This 15 a ~10r ob1ec:ive o! the SVCp,

., _ c~_

Contract

~".f!:.'.CS

~'cr !i~di~g,: Serlices and resources provided in closo collaboratlol du:I<1& the past year include: (1) bIcchemical ",ith :;c; i~ves:~gatcrs Itudiesof cc:: grovth reg~l.t{cn vith Dr. Iodaro; (2) actempts to (J) tests fo.r EBV ~!OlHe a :''=-':1 oar-CH v1~u, 'J!t~ Dr. Ba"ln; a~t~.en5 :~r ~r. Levine; (4) l~unological tests of leukemi3 patients, i~el~d!~~ st~dies ei tvi"s, for ~r. Lev!"e; (5) CF tests for gs a~tig@~s :~r ~r. ~ell~n; (6) ~~brane antigen preparation from ht::L1n ~~S3\:e !cr Jr. HerbH",an; (7). c;)lIection of familial cancer . sera a.!1C "is~'nie5 for Dr. Fra,reeni; (B) tj~sue I'Ind serum bank for ut. :'e-,ine ~ "31; (9) A:>erion ,,-,rkite reRIHry and follow-up; and (:0) ca:a preceAsiog ~lth Dr. ~aggoner.

cell

Initiated:

June

Level:

that this services

27,

contract required

C(,I\':~·'''''.

will to

mc.'!. ,:",

1969

$800,000

C. Y. ring

Ob!ect~ves: :0 ?revice a la,or3tor, that ~ill collect, process and test specl~e~s frem ~~an and a~ioal sources suspected of contaIning virus associated ant~gens or antibodies, and to provide other vIrc:ci7, i~unc:og1 or cell culture serJIces as required.

Rhesus

Contract

proposed supportive

!i.t.!.!:.:

Rl'SE:\I!CII

..!JIBS .. !_~!!i~

SupporlServiees

Contri1ctor's

~t

for

SVCP

f)_~~

'~ojcct

Officers

.._t!.~.!..:~l~!~)

(NC!):

Dr",

Dr. Dr. Or.

Hohcrt

Tin,!

Georp,e Todaro Paul l.evinc Robert Bas.in·

Obi~ctives": . To provide a laboratory an;) test cancer soecimens from human peeted of'e~ntainin~ virus associated

that

will

and

animal

I' .~~

eDll~ct. sourc('s

1"'<;11::.....

antigens.

Hajor studies were study carriedinitiated out under the <;u:"'r VISion l'ind~ngs:EBV of r. Paul Levine. Onc and compl.""" during this year was a scroepidemiological study c';mpar;IIi: FHV

titl""ro;.

in

Ampr;(":tn"p:lt1pnr'c:;,

a~c-and

sex-matcflcJ

African

Burkitt

with

riatients

Ivrnnhoma,

with

and

nllykitt'o;. acute

Iympl\{')ma

!vmp}\ocvtic

non-malignant

J.Ul...1

iC\J~Cnll_~

diseases.

·fi,l·

African Burkltt sera were significantly higher th~n the Amp,iean Burkitt ·sera (P(O.OOS). The role of "DV in human. ["",I'IIl""' WilS evaluated by immunological techniqlles ·detecling humoral and cellular immunity to the virus. The 'mportance of card ••l clinical evaluation was emphasized by a' study of twentv MI£L.-. ican atients with Burkitt's l·m homo and a e and sex matrh"d controls. reatment an pro~nosls corrc atc( Wit1 ca tll'.'rs in both I)'mphoma and Icukemia patients, indicating that s'.'1'·' epidemi610gical studies which include single samples on a . patient may be misleading. The studies clearly demonstr",,··1 that American pat!"ents with Burkitt's lymphoma, although 111"ir histopathology is iridistinguishahle from African pat len!:', hav. different immune patterns to EBV. Five individuals with low titers on an earlier study of Hodgkins a three year period. Half the while the other half maintained

to EBV who were identil ;",! disease Were followed over t; t"rs patients developed high low titers.

A studv of leukemia in identical twins was initiated to d('! .""f " r:line whether an antigen could be detected in the cells leukemia twin which would not be identi fied in his norma I Hi,,\ identical twin. Leukemia-assoi:iatcd antigens were dete.-r,'d in four of the seven families studied .to date usin~ the IYII'(ll1o cyte cytotoxicIty t~st. In the animal system, this test ,. positive only when the lymphocytes are presensitized by all antip-en, the reactivity family themember" the leukemicso that patient's cells but ofnot theagainst normal :ll!a""'1 th'.'S cells suggest that an envi ronmcntal agent, perhaps a vi rll';, is present.· .. Sera

to

from Bcl.ev

0/102 antigens.

had detect.ab.' breast disea;

(42\)

of

SeT:J

l,'ltibodies, and 3,6\

breast from

cancer 29\

whereas, of normal

of

patients

patient's

had wl th

13\ or pat icnts blood bank donors

an! .1,.. !i"s 5arcnW.1 wi th j,'.'~II1:11

r<.;I't'

....~.:.~

.~ -., {,~,


B! ONETI CS

Si~nifica~~~ to Bio~edical Research and the Pro ran of the InstltJte: ?~evlces opportunity or systematic, large-scale e::or: :0 ~et~ct· ir~ses or viral .antigens in human or animal =ateria:s usi~~ t ssue ~ulture. i~unological, biochenical and T is is a ~a5er objective of the SVCP. ~~ tec~ni:ues.

Ti

tie:

Project PrOD05e~ C~urse: A:1~oUi~ this ~bntract ~ill continue to supply necessary s~~?er:ive ser1ices ~o SVC?, the· wortseope has recently ~ee~ di~ided in:) three ~ajar ~reas, each being co·directed by a se:icr i~v!stiiator ~t Bio~etics an~ an NC! project officer. Drs. ~ei: anj Tocare will atte~pt te isolate, characterize,. a:d =uri!~ :~e !actc~:sJ in seru~ whlcn overcome contract Inhlb::IC: .rei~la[e_:~eJrowthcf ce .• s l~andc~.tJre. Jrs. lenta

and nor~al Bassln

andtransfor~ed Will atte~pt

to 3T3 rescue

l'nc~~

'\IH

at;c;;,;.'t~d

r

, I·. .

I;

;

11

! ,.

d ! !!

i I 11: ,

11

~

::j

':'J::e

'::0P.tl3ct :lumter t(1 "j,C'la:e

~j,

cJ.ncer"

.-\ IDS '::JScs reg3n

'" exhibit

.::ou~kd infectiC'n.

\·iruses.

<Jbo\·c. Bionetics

Specific3l1y.

,hc unprecedented

\'. i:h dramatic anJ cm these

st.lted in the .::('m~;).::t unJ~r

resc<Jrchers

Ep;;tcin-Barr

(E8V).

leukemia-lymphoma-sarcOllia

"P~C'pC'sed Course:"

Bionctics

collaboraiors

\\ere

ap-

.(\ I. J. 9-;

in :a05 due to the· <Jbsence of sophisticated

B. \101C'r.e:;. Ed .. Washington. I Q-: I and Refercnce

i 3Dd

biotechnol-

D.

c.: L".S.

= HE

Go\·emment 20.31 ':;2:\·3I.Scc

(

:: t~-I

.

11:!1'\'c\' I\:d.jn

1)1' .•

cytology

and

OVul.ltory

drul!'

:lre

1

" .

(.

is

be ing give.n to the squi.rrel, marmosct, on study are being

I:

New It/orld spec i,!~: ,·1 ·and spider lIIonk".· actively Clllled tu , .. :

, ...

k':

i

Print· also:

Hl'rcwitz LG ,1:1': \'1J.r:in \\'J. El1Il'rgill.? fir/l.'e.:>: . liDS & Eho{tI-~.\"(Jl/Irc .. ·lecid"'1! ·;r /'1i<":;:,)':.;!.' Rc'ck •.,'n. \'1.\: TctmhcdT0n Press. 149:<. r"r additional disCll':";C:1S.

,1'1:' I ..

Special emphasis has been pla~ed on virologital studies characterizing the Mason-Pfizer monke)' virus (~1· P~·I\'). :,"·;t'l sublines established from chronically ~1·p~1V· infected rh,·.;:, foreskin cultures were shown to be releasing moderate! y J" ,", titers of infectiou.s M-PMV, and in addition seemed to hH" undergone in vitro transformation. Inoculation of CL'I.l·' .' these suh] ines into newborn rhesus monkevs prouuceJ pa 11-": masses at the· sites of inoculation. lJiopsies pcrC<)rncd n •. these masses and on the reRional lymph nodes of the sam,' animals revealed the presence of prol i ferat iflg \. ru~ (h:1 :.. ,. t:·, istic of M-P~IV Dj' both electron microscopic nnu cell (u!:·::·· analysis. Proliferating M'P~IV was found in the lymph nod,': oC monkeys inoculated with cell-free M-PMV prepar~tions.

Iym;.'!-.l'mi sar.:cma. 3:1d E8\' panicles genes to create. then "rescllc" (i.e .. isobte '. :iC·.\· T:1u;mt ::iDj;]S cl' deadly \·iruses th<J1 produced AIDS-like symptoms much :ike !-iI\·. S:0ur~~: '\CI 5<arT. rh.: Sp.:cia{ rims Cmcer Program: Progress R<.:',.:r:.< :0, ',;!:,j =S; '. OtT;c~ c'( [h.: Associate Scientitic Director for Viral Oncolj

I'r

!Jr. Hoy. Kinard Dr . .Jack Crub,'r Dr.·G,ny Pcarsn!1

vaginal needed .

New importance monkeys,including Animals currently this change ..

immune suppression, particularly upon two specific far-remo\'ed continents. As

vg:; Jikgecly l!nJ\ Jiia~;e ;;'dim themid-19-0s. "Co-culti\3tion" and "hybridiz;nicn" r~!~:- ,0 the g:ri~SSmi\in~. in-\·i\ 0 and in-\·itro of. for instance. Icukemia.

l'g:.' 0.-\50\ ing OtTic~.

in

Inocul·ated and control infants.are hanJ-fed and kCi't in modified ·germ-free isolators. They·art· removed· CralP. is,·' at about 8 weeks of age and placed in filtered ai r (;>r.e,: months or years of ohservation. The holding arc:! Ill)" c"nl' approximately 1200 <lnimals up to S years old. Approxi.nnt·· 300 are culled every year at a rate of about 25 per mon::'. This is necessary to make room for young animals illoc.ltl;>r.··, with n~w or· improved virus preparations.

parc;};I:; SULL~SS:Ui. .:?iwn the .-\lDS pandemic. in their "attempt to rescu~ and isol:He J \'iT3i ge~C'f1'e ... frC'm untreated patients by co-culti\·ation. hybridizatien. JnJ vth~r [e.:~niqucs."· This dispro\es ofTicial reports that 111\' could not ha\ e t-e~n "-:c'Il5i>t:ceJ"

lJirl:~.~;

Officer.s(NCI):

insemination; or tried as

!eC!k~:l1ia. IYr.1rhl'ma. and 53rcoma \·irus panicles weresrudi.:d frequcntly in age and s~x maTched _.\merican :md A.frican p3tients· "in selected dise3se groups."' These contra.::" ·,\·ere initiated in I 969~appro:\imatcly ien ye:HS before the first c<Jncer Lom~:e\ EB\' .::C'-factN

C:Jrcinr).~t'nl'si';

1969

/:'9·21 AI) d0cumcnted

human

Project

Viral

~lajor· Findings: This contractor cont inlles to prodUCt' r)\·· 300 excellent newborn monkeys per year. Thi$ j, maJ·" I'" by diligent· attention to reproductive physiulogical star,· female and m,de breeders. Semen evaluation, ;JrtiCical

pncr3 a:a jreas: C3C:~:. I~ the leu'e~ia studies, special e~~~a5Is 0111 ce ?lac~ci on test:ng patients who nave an loent:ca:. t· •.in; i:! the :y~;;ho:1a stu<!ies, the seru",s of patients in se:e~[ed disease iTOV?S will be test~d for a:ltibodies to EBV.

. Jat~ C~i1tra.:: I:::tiatec:

of

(r;!..!l .. _!.L.~~:.~-~)

Objectives: (1) Evaluation of long-term UII(ogt'!:j,.: t':·('··. human and animal .viral inocula tn prim;)[('5 of v:lriou:; ~I'" ; .. especially newborn macaques; (2) ma intenan-:e of monl·.''''· I·,·· !! ·i~: colonies and laboratories necessarv fo:- ino(,llat iun, -::,,. ; .. ,; monitoring of monkeys; and (3) bioche"'ical st::dlcs of (11' RNA under conditions of neoplastic·transfnrm:ltioll :in,j <1·;1 on the significance of RNfI-dependent DNA pol:;mer.1Sc' il: !.,!., leukemic tissues.

an~ iSJ_a:e a Viral iene~e tn u~altte~entlatea sarcomas fron oy co-cultIvatIon, nyorlalzatlon, ana other unt~eatea ?a::ents tec::lc~es. JrS. Lev:ne ana ring wlil contInue stuales to ae:e:, tu~or SJ~::::c ar.tl<~ns :n patlents WIth leu~emla, lvm-

a

Investigations

Contractor's

!i'\c'

LAUORfI T()[!~I1;:;.

RESEAI~CII

, .

Chromatographic control and vii.

·amination transformed

of

transfer rat

and

RNA's mouse

(tI~NA's)

embryo

cell

rr~n s _.... ~

i


d~~onstrated differenc~s in phenyl-alariyl-tRNA's and aspartyl-. ::~S-\' s. ~o ci fferences wer~ noted in the elut ion profi les of 5~r::l-, tyrosyl-, leucyl-, asparaginyl-, or glutaminyl-tR:-.I,\, 7~e effects of 11 rifamyci~ derivatives on ~iral··reverse tra~scriptase and on DNA po~ymerases from human normal and ~~~~e~ic blood lycphocy:es were evaluated. CompoUnd 143-483, 3'!br~ 1 rifa~ycin SV:. octyl oxime showed the greatesi ·from both viral aed ~o~e~~ a~d.i~hibited al: )~A polymerasei

Title:

r orlg1~s,

c~.lu_ T:-:e

MERCK ANDCOMPANY, IN~.

~ar

C:'fi:

alsl1

~n(aie:i

i:-,

c;rlld~ps

c311ahorative

Oncogenic Virus Res.earch and Vaccine Development

Contracto.r's

invnl'Ji"&

c~cc virus: RD-114. fro~ a human sarCOma i'olated by ::5. ~cA ster, Gard~ner. and Huebner. The virus is ·being· ~r duced and supplied by Dr. Gilded of Flow Laboratories. A~ t~er virus, a ~u~an papovav!rus associated with progressive :::: :ifccal le~:':cencephalopa~hy, is being suppl ied by Dr. Duard ~; ~er :o~ i~cc~lat:c~ i~t~ newborn monkeys.

(NIH-7l~2059)

Project

Director:

·Dr. Haurice lIilleman

:Je

S!ini icance t~ Biooedical ~esearc~ and to the Pro ram of the I~st: Jte: I~as~uch as :es:s :cr t e Dl0Iogi~a. activity ot C5J3: ate hu~an ¥:ruses .:1: no: 3e tested in the human species :: is :~perativ~ :hat aJo~her system be developed for these ~~:~r~inat:o~5 a~d. subseGu~ntlv for the eval~ation of vaccines or ct~er 3easures of centiol. the close phylogenetic relation5~ip of t~e lower pri~ates to ~an justifies utilization of :~~se a~iJals for these ur~oses. Further study of altered :ra~s r ~~A a~~ Dolv~er ~e'en:v~e5 would deter~ine their sii~i ca~ce in n~opiast c c~a~~e and provide· a basis for s~lec GO c~ thera?eutic ag~nts: .

-

do o

Project

~a:e

:ontract

~~rre~~

i !

StCP

Annual

~ill

i~itiateci: Level:

12,

.

work.is progressing September, 1972•.

5:,1)3,850

i

\ ., ._ t't'

on schedule.

The projected

completion date is

Turnor-specific cellular vaccine development: The preparation and aS5.1Y of tumor cell vaccines.for protective efficacy in the·hamster model system was continued at a lower priority level. Testing of adenovi r:ls )1 turnor.cell fractions prepared by mechanical disruption of the cells and fractionation by differenti~l centrifugation I.'ascompletcd. None of the vaccines (crude cell homogenate~ nuclear fraction-w2l = 107

1962

:'\umewus .-\lDS-likc R:'\.-\ tulllor retrol'irus hlbrids \I·ere biocnQineercd under the 3tO\ e contract. Related elTol15 bCQan as carl;' as 1962. 111A fri~a. Bionetics-bred . monkeys wcre inoculated with rcco~llbinanl st;ains of imm\1ne-surprcs~i,·e can:ino£e;]jc \·iruses actin!! a5 co factors with other biolo!!ical and chcmical ;lQonIS. as deuiied 3b\"·e . For inslancc. the RO 11~ I·irus rererre-d to II·as a cat humal; hybrid Ihat. 3ccC'rding to Or. Gildcn_ "may be accidcmally imroduced in a ncw species. perhaps by \accine .. .-- :'\ole the ".-\uStralian antigen" (i.c .. hepatitis B lirus) gi,·cn to ,Hri-. C:ln ,:reen mL'nke-,-s unde, contracts numbered -:1-2025 ~nJ 7 -2059, :\ftlch cI·idcncc >trt'!1giy sugge,;t; laccine re~c;JTchtriggercd thc .-\IOS panJclllic. St)\lTce: Horo\\'itz and :\ lanif'. Up efT .. p. 511. I

Dr. Robert A. Hanaker Mr. J. Thomas Lewin

Major Findings: Multiple construction and renovation projects ha'/P (·!cr. involved in the expansion and reorientation for this program. Remod\':tag of a laboratory, physically separated from the animal turnor virusareJ, was recently completed and is in use for Herpes simplex type 2 vau In~ w~rk. Two rooms (440 sq. ft.) in Bldg. 1/43 were remodeled and equlpp'!ci and are in use for the germ-free derivation of kittens for the SPF C~C colony breeding nucleus. ·Plans were completed for the renovation of half of Bldg. 1/65 (5,940 sq. ft.) for housing an SPF cat colony and for housing experimental cats •. The construction and equippinp' of the ilew biohazard containment building 0268 (12,096 sq. ft.) for laborato:y

cont:r.ue.

recruar:

(NCI):

Objectives: To c·onduct investil1.ations desil1.ned to develop vaccine~; ar other agents effective for the prophylaxis and therapy for human neoplasia of suspected viral etiology.

?rJDo}ei Ccuise: T~e previously ~entioned·studies will be cO~~1nued ana expanGed. Particular attention will be given to r~5earc~ en a~i~als inocJlated with candidate human cancer .irus~s, a~d investigations will be carried forward into the na: r~ 0: neoplast:c c~anges and their possibl~ control at the ce~ ular level. Collaborative efforts with other researchers

~i~ i~ t~e

Officers

~

pellet, membrane fraction-w2t = 5 x 109 pellet, particulate fract 10n-)t lOll pellet, cell sap-w2t = 1011 supernate) protected hamsters against development of tumors when they were challenged by inoculation of vi,lble. homologous turnor cells. Work on the preparation of two other types (If tumor cell antigens was continued. Cell membranes ~ere prepared froro a adenovirus 12 turnor cells by hypotonic extraction and ;,rere ·solubi] i7.~·J by sonication. TI-- solubilized material was fractionated on Sepharle.~G;'C'

\

.


',.~.,

f ~-

col~s

a~d :~e desired

(raction

concentrated

by the Diaflo

has been in progress for t~o mOllths. All eight isolators are n'-'-lIf'; ",I by kittens (16 females, 7 males) ranging from 1 to 8 ~,;eks il1 ,Ig'·.

mecbrane

tec~,:1~~'Je. :he E:st batch of test and cont:ol antigens 15 on test for protecti'Je ef~icacy in hansters. Preparation of additional batches Technology is ~tili,being developed of antige~ !D: assay is in ?rog:ess. for t~e Fre"ara::on of adenovirus 7 tuoor cell me~ranes by flo~ sonicatior. aJ~ ::0. z~3ai :e~~ri:ugaticn.

Significance.toBiomedical If

)"":)5t of ::;e experi=eJts

results pre?arec i~terfere t~r

ce l' __s.

~

Q

i.'1 this

series

are on test.

af:er

vacci:atic:1

~ith

5 x lC6 ~-irradiated

At:~pts :0 :eJce: Jcop:otec:ive 5V~O tu-~r cell vaccines the ad:li:Jis::atic:: Jf ;:oly I:C beiore, si::lUl:aneouslY'Jith, vaccL,e, si:gle J: nul:ip:e doses, or by di~ferent routes s'.:ccessi-.Jl ::: :::e, :'uster xdel syste::!.

effective by or after ~ere'not

5t::<5ie5 er. :::e ro:e c: fetal :c~ciuctec =-= t~e 5Voo-:'a:ster

are being series of

antigens in tu=r :mt:Oology ~del systeo. In the first

erpe~:'.:Je:::, ",-i:rac:a:ed. 9-12 day gestation fetal cells of ::!ultiparous crigi:l :::.c, :!c~ ?rotec: aC:Lt !:.ale or female ha:nsters against tUJ:Ior =e~el~~~t .~e:! :~:lenged ·':th SOCOho~10gous tumor cells. Experiments from Fimaparous 10' are iD pr:>gress "~e!eb the nccbes ~ere prepared day ges:atic:1 wTj':!s and are' bei:1g 'tested iJ the 5V40 virus-ne·.born hamster ~del SjSt~ a5c in the adult ha::!ster-t~r cell challenge system ~ith . a 2300 ce:l ch.allenge cose.,

if

tt

strai~ of feline leuke!Dia virus (Ft'/) ·..•as 1.1e IT (!..ava~ni-i:eile:l) rcut:ne:~ prooa£a::ec i~ rol:er jottle (1 l:ter/bottle) suspension cultures !l./4c eel: Ibe. Te., liter 'lots of culture fluid of t::e vir--Js-shedci:g o~re c~ce:!t:a:ec (:CCC~) and purified ~y'flo~ zooal ce:1trifugation an:: isopy:1:c ce:!t:ii';gatio:: :>n sucrose gradients. Modifications in tec:'no!c\:.,. .lie sti:: bein~ :lade to increase' :h'e purHy of the concentrated ·lirus.·'-i:-Js :>ie:ds of 10:3 ';i:us ?articles!al '~erereacily achieved.

H

'I r,

I:

~: "

Date Contract Current

~ck \t' .

p, ): ':.

:i>

Level:

in

the

genesis

of

somc

hUr.1.1I1 C.lnl"':"·:,

function

RS

co-f~ctors

essential

ill

cXDrcssio:l

~:

Study of Viruses

contractor's Project

Project

Of ficer,

March I,

1971

$1,016,000

and Company, rnc.

(NIII-71-20S9) in lIuman and Animal Neoplasia

Director:

(NCI):

I""\'

Dr. Maurlce

R.

.

lIilleman

Dr. Robert A. Manaker Dr. Jack Gruber

;'i~

.t,:i

" ~'I

Objectives: other agents of suspected

To perform Investigations designed to develop vaccine. or effective for the prophylaxis and therapy ,of human neop!"·:j., viral etiology.

Major_Findings:

'\i ,:

~:

~ I:.

This

is a new contract.

Significance to Biomedical Rese~rch and the 'Program~f the Institute: Current d~t~ support the concept that a'virus or viruses are the essent i,,1 element in most animal tumors studied and that viruses are probably tt". etioiogical

be greatly

Influenced

component

in human neoplasitl,

and modified

by host

(

killed .•... \;,...

vi rus .vaccln~ ..

( possibly

though'

expression

and environmental

viruses ar'c the 'essential ·element In human cancer vaccines to pre.vent or minimize infection should to cancer preventiol '''his could be .1ccomplished

( :2 r; •.. ,

Initiated:

Annual

necessary

1:1 orde: :0 ?rcv:ce a:! ace~uate supply of healthy cats for future experi~'tal "~rt, esra:l:s:c:ent of a s?ecific pathogen-free cat colony ~4s pr:!~cse:i. :r,e i·i:s: ster, the ge:cJI-f:ee de:ivatioo of "he breeding

element

Proposed Course: Ef forts to prepare tumor-specif ic cellut,1r ant i80:1'; for immunoprophylaxis of cancer and to study the 'immunologic respon,,· to such ~ntigens ~ill continue. Tests ~ith poly ric for adjuvant effect on ineffective cellular vaccines ~ill be completed. Work to~ards development of a felIne leukemia-sarcoma virus vacc in~c! a herpesVlrus type L vacClne ~lii be contlmJed as rapl'dly as posSlhJ,·. If no problems anse, the germtree derivation of klttens tor the SI',' cat colony should 'be compieted in several months.

.

'::!'.rS vac:i:!e :e'lelo;oe:1t: :1:is project is still in the initial stages. :he "~r~ in ~ro~ress is cODcerTIed ori~rilv ~ith basic needs such' as virus ?rc?agat:co, .ir:Js c:!Dcentration and purification, preparation of s?ecii~c act:sera, a=d estabiist::!e:1: of routine assay prccedures.

essential

0.1 neoplasia.' and immunity against such secondary agents might pre",''': expression of the'neoplastic state. In addition, vaccination ~ith ,homologous virus in a virus-dependent cancer may enhance specific humoral antibody or cellular immunity. This research project is of fundamental importance to total program.

SV40 tumor

'

an

viruse~ may

oncogenic

Final

v::h cne Jf the ~o~protec:ive vaccines, 5'40 t~r cell ghosts ~: hy?er:c~ic extraction, sho_ed t~at this vaccine did not ~ith the ability' cf the host to reject viable homologous

ce:ls

are

and the Program of tl~~_.1~t,::"~'.t,'::'

prnphylaxis by vaccines to prevent or minimize infection 5111"',1.1 prnl'i,!·· a rational ap'proach to cancer prevention. This could be ;)CCl'mrl isl".: by living or killed virus vaccines or possibly by vaccincs of Pllrirt.·.' virion sub-units. AJthough greatest benefit could be derived h:: pr.' ventio~ of infictions transmitted horizon~aily after birth. a polen! i,' benefit from vaccines may be derived where viruses are transmitted vertically but do not express their full antigenic complement. ~"n

:n~es::5a::cn =: :~e hest i=cunologic respo~se to nonprctective tUDOr eel: 'Ja:::'::es is :e:':1g cor.duc:ed in hamster-tlll!:or ~odel syste!!ls. T!1e fin: series of e:r,eri::e::ts '~as designed' to test :he effect of Inoc:Jlation Jf ~no'~ nO:1~rote:~ive vacci:1es before, si~ul:aneously ~i:h, or after 'l=I.L,izati:J:J '~i:!;'a boo'!: e!iective vacci:1e (5 x 106 y-irradiated tumor cells).

viruses'

Research

t

then

provide by

prophylaxi~ a.

virion

I"

by

ratior~al

utilization

by vacc ines of purified

In;t·:

factors.

nr

<"1'1".'.1'

1 jIlt'

""hun

II!~

f'r

h


Vaccines

would

obviously

provide

their greatest

with

oncogenic

viruses

transmitted

infection However,

even

.agents does viruses

the

out

function

as essential

and immunity

enhanced

against

state.

this

goals of SVCP

Proposed methods

Course:

·present

with

can

and "B" and

investigations

"C" type

l.'i11be conducted. optimal

vaccines

Particular methods

quantitation,

vaccine

Date Contract

Initiated:

to cause

assessment,

March

specific

viral

and vaccine

quantitation At

model

live systems

to developing inactivation,

potency

the

(DNA) viruses

to evolve

animal

given

to developing

in man.

herpes-type

studies

be

attenuation,

and

to the

program.

efforts

cancer

Parallel

will

total

initial

in appropriate

attention

for viral

safety

devote

~ancer.

importance

to the

the

may be

in virus-dependent

be foc.used upon

particles.

virus

or cellular· immunity

concentration

or shown

Nononcogenic

expression·of

is of fundamental

will

neoplastic

of neoplasia,

prevent

contributions

will

(RNA)

from vaccines.

virus

purification,

suspected

attenuated. and killed

applying

unique

The. investigators

viruses

time,

homologous

birth.

of hypothetical

might

antibody

after

in expression

agents

investigation make

for propagation,

of candidate

secondary

Additionally,

research and

benefit

cofactors

in preventing

horizontally

transmission

a potential

such

by vaccination

Obviously

vertical

not rule

may

neoplastic

possible

benefit

·and viral

assay.

1

1, 1971

"Combine these two diseases-feline Icukemiaand hepatitis-and you have the immune deficiency" syndromc today callcd AIDS, said CDC hepatitis B chief . Dr. Don Francisat the onset of the pandemic. As stated in the above contract, Merck investigators developed "methods of propagation. purification. concentration, and specific· quantitation· of candidate viruses suspected or shown to cause cancer in man." Among these was the "KT strain of feline leukemia virus (FLV)"concentrated to "IO~ \'irus particles/ml:' This"C' type (RNA) tui110r retrovirus. according to leading expert Or. George Todaro. \vas another manmade virus that apparently e\'olved during· similar cancer virus hybridization studies, as in the case of the RD 114 cat/human mutant. and/or vaccine experi. ments involving cross spt:cies transfers of infectious particles. As stated above. in response to these laboratory studies, authorities knew as early as 1970 that "non-oncogenic \'iruses rriay function.. as essential co-factors in exprt:ssion of neoplasia (cancer). and immunity against such secondary agents might prevent expression of the neoplastic state," For this reason. these cancer vinis and vaccine studies focused on the herpes type (DNA) viruses. especially EB\'. QS infectious co-factors to r~glllatc rctro\·iral carcinogenesis ~:l!ong \vith other chc::mica! immune modulators, E\·idcnce· is fim1ly cstablishtd~ therefore. that the hepatitis B \'irus and \'accine research. conducted simultaneullslv in N'iC and Central Africa bet\Ve~n 1970 and 1975 under the precedin~ Bi;neti~s and f\1crckcon. tracts. invoh'ing infected monkeys and chill1panze~~ used for vaccine produc. tion. was extremely risky Zlnd circumstantially linked to the AIDS panckmic.For primary sourct:s and additi()nal background regarding this iml'DrLlnt lh6is ~cc: t'l(~~-()\\'ir" •. ~. '.L . ·l-...:... i~i'..';lr

LC~ _J e)1"

:'11 r \1'1t-r: •• ~ ••••1 .1 •..\1

"/!:,r·i...!:t-:-~)l:..:/,.r

•••••

••

\\'-1

'"

;~nil'1":r;I/~' · ..••• 1 .•

.~'"

~Z..\...:k~)..,:·~. \

_

(';;'!!\,,\ •

I ••••.••••

_!/f):.. : 1.~·

.•. ·

\..\..••

:'~ij·-' ~; ..•••••••.••••.•.

1:\: ~[·· .... \tr~dl'.,.:...~:·l';': P~·,-··~~.: ~)'..~\

\'

"i'r,"

II i

I


"~\. 11

Pu6fic

'Dclltl; iT! tlic :1ir

fl

J{ca[tfi,

J/mericall

:Mclicillc

alll

'.R.!l((!:f~·a;·,. :f

tlic

11/111//1

'Il, " f'

I! I· t-.

C:JN7?.AC'

!U:?I}!TS

~ Cr,iCE

OF PROG~U,

,EoCUPC£;

;

U:'GliTiCS

US-USSR Agreement. of the microbiology,

Dr. J~ek 5ruber, Chief, ~PP.&L, 'G?, DCC? Dr: ~rr~tt 'I, (.eef~r. SUff Sci~nt;s~, cp:m, YO? XC? iff. John S. Cale II!, S~ff Sc;:nti;:, SFO:~L, ';CP, y.:?

(, \I

I

! ftf.Em~.~

!I '1

Title: Vi ruses

;-(jJE C;;LT)E C~ntorjal

Contractor's

"o

Pro;ect

..-

COlL::C~:C.~

?~eserlation

Pro;ec:

~fficer'S

Dr. Dr.

(tiC:}:

i;r. Jctin

Charles

Delegation

of °ei2renc~·Grade

fr~

~!ie '(inl

colhbor!t~.ng

~nc~logy ?!''Jgr~m. io

ef ""'~rials

af

~hich

pro'/~tje

As agreed, Virology,

correlati-::11

bet,,~enio

vi;'!"I)

actiYi!v

in '';yo .• ni:! an IPrarfnt

in :1d~titl

virology.

to ~:C!

feline

by ~c'5e

~.ary

~IH

3S;3VS

:r" fer

:r.e

~~H'3:fo!l Jr the 3tJpr~)'Ielj

t'. ...__._.... h __.

u ••• __

• __

._

and car.c~r ir.J~tJy thri:'U1h Rc,::k~fella l'np,'e"i51[Y Pr.esident. Dr. Joshua Ledem"..g. cC'minjt1N lCS th3, ",igclI- t.: .:cn;,dued ~e:lSC'r.~u~ b~' ;Urrl\ 109 biologic"1 We3p<'ns. incluJing !e·A=i.·ir.-dt:cing J/1d .\IDS·1ik~ retn" iruses 10 potential cncmics. including R'-I:>!i311:ai->. duir:!! ill< Cdd Wir. Dr. L~l!ert'<:n;(; l'r£"nila,iC'n. thc Senalc Ricglc biologic,l wc"pons R~p<'n \'n L"e Guli \\'2T ;:•.,,In:,me ;l1I~J. had >hin'Cd SaJam fi~,'ein'; labs a ~rC"_>d:lfrJ'" t'f '.;111.'0 ;hcnh' t.:il',e froo in\aded KJ\\.il. D,. Leeeme,!!. a eFR ;tudv

).

1~r ··"\("o~;~t.i.11\\'~f1~r~'· J.I1d Hi",'IC'gical \\'t"3J:X'ns rlanning. i31:::d~'dcnit:d, er :h~ r~~ugcn . .10: ~i('k'~icJI\\e'::!f-'.'ns ~"(p.)~ure-5 IQ tn""r.; Juring the war. Fr0m: ~eJ StalT. 1',,' .'5.~,-,;,;:l I'r.,.< Cme," pn'l!r,;O! :S:·CP/. 1.'.S. D"pnmelll or

. ',

Ikallh.

Educ2';l'n

.~

1ns:til\n~

('f H~3i!h. Dj', i~lcn ,-'f CJn('~r- CJU'~ Jnd p~~'. ~nlil'n. ':3U num~:-: F.':(I_':~::·\''': 0-- Jr.d -"-:"11~~.

direL"'":l'f

{)n t-<h.Jlf

Libr3.r:.

3,0

Sukhumi,

USSR

Bethesda,

USA

Ri9a •. latvian

1978

SSR

\\"~b,~.

W,.'him!1C'n.

D.e.:

P:J~Ii~ fkllth

Se" Ice. June

!I)-S.

:""i,'n,,1 p.

Group on Cancer Zhdanov, took

~_10,

The main emphasis

of

this

meeting

was given

to reviewing

results of a study to determine of leukemia in baboons. This

problcm of of Kansas)

the re-

the role of genetic \lork, conducted jointJ~:

USSR. is an excellent example under the US-USSR Agreement.

of

the

The Chairmen of both Sides reported on the recorrrnendations made in the Memorandum of Understanding of the Joint Corrmittee on f1a1ignant Ne~p 1015 i,i held in Hoscow, USSR, September, 1977. The recollJ11endations included:

,!lror ·/irus.

C(}~rse: Titis contract" ..-ill ccntiltlle

Jr.d

1977

by laboratories in the USA and in the cooperative research efforts sponsored

;f eC'jtr~~~( \'iit:~e; ~:i~

\:(lmplc:'(

group

ri~r

flosCOli, USSR Bethesda, USA (Subcol1'mittce) . r~oscow, USSR Bethesda, USA

the fifth m~eting of the US-USSR Joint florking Co-Chairmen Or. J.B. lIoloney and Professor V.lt

presented preliminary' factors in an outbreak

tT3n~fQT7.at~on of ~up:,id

pt~n ..

d,,<::o...,·.,.,· :~:h:

procedures and scienti;':

progress 'of current cooperative efforts and assessing the combinant DNA research. Or. r~ichael Crawford (University

Sicnifjcan<;~ to Sioce'1i,al ~es~~r~:t H'~ :~:~ ?r:cn;: -:;f ::e 'nstit'1t~: Virus zta!.eriais !re s;Jpylie-:1 ~ ir."2st;~at.ars t!lr'Ju~~-c:Jtt~e .crij 0'1 t'rognr!' i(esoc;rces and logisti,;.~. I: ~s 1::::<:ru:'!t :h:3! highiy ::.aracterizert r~fF"e"ce stocks of :.!-~se ·/~i.iSeS b-e av!ihbje.

~sed project

1972

November, 1973 Nay, 1974 l1ay, 1975 June. 1976

ished

infonnation,.iTtaterials

place at the National Institutes of Health,·Bethesda, r·:aryland, USA, on October 26-28, 1977. At a symposium held on October 27 and 28. members of both delegations and invited speakers presented recent st~dies in cancer

.:oc..'1i',er::ed 'his,~,ries

r.aY~ been pr~vidE~

leukB!!\Jgenic cel1s.

. November,

of

;~rT!:!~:'(~ Ke2fer

investigAtors.

a TaCt

The 11emorandum establ

exchange

September,

~i!

S. Cole

18, i~72.

October,

t'djor ~;nd~r,fjs: '~eipl and c.1arzc:.eriL3dcn of '::iiG:;::1:: .irvs:s frt::1 p;"c~;·r..:: ResC'~rces md Logistics has continued. Dat.! on ,1\~ Cire:ted DNApoly:::erase of five rurfne !r.d ~ ;Jrl"..ate V'J"'I1SeS h.J~ t~~n de·~e\c::ed. Se!"!:b9k:a~' ao.alysis of 951 u)d gsJ anti;~n sugses~ ~ s~'~ng cross reac.t1'/1ty t'-P.t·~€e" squirrel ronkey r-etr:::yir~s and 1'a5=n-Ffize~ \l;)nkey Vir;s. The :entrac~' reports

fleetings:

~.. ~ldr;o

!'>.i historically trace t.~e origin To ~iclcg;cal1l c~.!rac:eri~g of se1ec:e1 =r~f':::S ,f t.F.!Or vir:Js~s. ir:cl~jir.g ayi~n, ::urir.e. f~~ ice, ar.d pTi!r.3~e·t in cr~~;'~o jeve.lc, 3n::i Cbt3io referenc!!-gra~e ~•.• ~r 'drus :r~~eridls. To serve as an 3rc~iv~1 r~'Jsitory for see-j Sleeks ~f itportan: 'drus

and char;cterin:icns

on November

T:P'.or

~~~tives:

mterhl>

signed

joint studies through the betwecn the hiO countries.

('iOH?+ E!7)

~nd :Jevel~!re'nt

~irec:ors:

first

A f1emoranctllm of. Understanding for coopera tion in the'! ".!:' irrrnunoloQY, and molecular biology of cancer viruses .·'I~·

i ,~

.,

';~', ~'~Yi\~.".

(2) (1) discussing, increasing the in program depth. cooperative partiCipation studies of other on recombinant USSR institutions, DNA research, in particular to include the Institute of liolecular Biology, lioscow, (3) C~n· ducting exchanges of scientists only under the auspices of the Cancer Virology Program under the topic of MaI i9nant Neoplasia, USA-USSR Hea 1th Agreement, and (4) encouraging the use 'of small working group meetiogs 1)11 subjects' of intense interest. .. Delegates expressed interest in conducting collaborative studies in the. following areas: (1) studies of viruses isolated from human tisslJes in ,;cl! culture or in animals and their possible role in the pathogenesis of h,",.ll1 neoplasia; (2) continuation of studies on non-human primate viruses as' [ill'" relate to human cancer; (3) studies on the role of viruses in the indu(~i"'l of human breast tumors, inc1uding continuation of studies on I1PMVand rcl,)" d viruses; (4) studies on cocarcinngenesisuvirul/vi:'al, virol/cl:e:::icill. or:.; viral/hormonal; (~) characterization of nucleic acid~ and their role ill 1.1'" induction of animal and human cancers, particula;-ly the detection of tra'1s· forming sequences in .cellular nucleic acids and molecular genetic studie· . with DNA from human tumor cells; (6) studies on viral proteins as proboc for viral gene expression in animals and hun\1ns; and (7) studies on onC"':",!,; viruses important to hUf1lJn ecology. e.g., those derived from bovine. a:,i'III,

\

.! ;-I


.0../ ••••••.••••• 1 •••••.

)iur

"CM

1•..

[01(,0

Figure .16.5. US-USSR Agreement Continued TO U.S.

(continued)

INSTITUTIONS· February,

Dr. 1. Kryukova Gamaleya

M.D.

1976

Anderson

lnst. Prof. S.M. Klimenko Inst.,

Hosp.

Michigan Cancer NCI scientists;

Inst.,. Moscow

Ivanovsky

VISITED

September,

NC!

1976

(Dr. Hanafusa)

scientists;

Research

Moscow

(Dr. BO'ilen);

Fdn (Dr. Rich);' Rockefeller

Inst.

(Dr.

Cancer

Blumberg)

.

I I

J

Dr. E. Bagley Kiev Inst. Experimental and Clinical

NCI

March,1977

.0

scientists;

Cancer

Ctr

F. Hutchinson

(Dr. Hakomori);

Sloari-Kettering

Oncology

Institute

(Dr. Sonnenberg) Dr. Z. Butenko

NCI

March,1977

and Clinical Dr.·S.A.

May,

Ivanovsky

Research

of Chicago

November,

.

NCI

1977

Laboratory

of Viral

Carcinogenesis, Viral Oncology Program

Institute.

Preparations

Institute

Oncology,

April,

NCI (Dr.

1978

Leningrad

Lapir.

Di rector,

Ins t. for

·Experimental and Therapy,

September,

RQizman~

yi~it was to gain

UCLA·(Baluda);

Sl~an-

Kettering

Benc!ich)

NCI

(Dr.

scientists;

Kettering

Sloan-

lnst.

(Dr. Moore-

. Jankowsky); Delta Regional Primate Ctr (Dr. Gerone).

Se;lior Scientifi~

~·joscow,spent

Dr. Bernard

1978

Pathology Sukh~mi

P. Filatov,

Galll\); USC(Drs. and Vogt);

McA11ister

of

Dr. Boris

Virology,

Uni'versity

(Dr. B. Roizman)

Prof. ·I.F..Seitz

. Dr. Felix

1977

Inst., Moscow

of Viral

Petrov

~layyasi.

E. Cronkite

1977

September.,

Dr. ·L:B. Stepanova Dr. O.B. Kdrchak Moscow

laboratories

Ihst., Moscow

Dr. Felix Filatov

Researcner,

tl1ree-and-one-ha1f

University

experience

of Chicago.

in

months The

(~) preparative

Ivanovsky in the

purpose

Institut~

laboratory

of

of

of hi~ exchange

purification

of HerJes

The above agreement includes a partial list of researchers. including Dr. Rohert Gall\1 \)f the NC!. who traded the most advanced methods and materials in the fields of molecular biology. bacteriology and \·irology during the Cold War. InclutkJwas the "brge-seak production of human yirus" tmnsferred to the Soviets by Dr. Gallo. Might this h:.m: been the AIDS virus'!· Additionally. besides possible treason for traJing biological wcapons technical knowledge. and the weapons themselves. with the Russians. these documents clearly reflt;et the functioning of glohal cryplocracy that supen.:cded the gc\)r\)liti~al p,)li·;.:ics o!" the UnilcJ Sla\~'s Co\\.:rnm~nl. and knowlcuge or th~" :\merican \,\,,"1,1pk. Fr\Hl1: ,,\(1 Suff. O!' :·i:. 1l)-". rr. ~(,:lIld .;()o Library cd! numb\..",: [.:~{\ ..; 1:,2Y,,! l)-"7 I .,q... \,..I -"'_,'-' I \.1.--•••••. Cl

;.

...•-0") _"")'1

_

I ! \

Spiegelman,

W. Moloney,

Oncolqgy

Novakhatskiy·

Ivanovsky

scientists;

of Drs.

Kiev Inst. Experimental

!I ,


:.ueatn

z.n

the Yiir \ j

IOC]

j

FIg. 18.6. David Baltimore HIV/AIDS-Iike Virus'

Study at MASSACHUSETTS

Title:

MU During

INSTITUTE

OF TECHNOLOGY

Studi~s on the Leukemia Virus O~oAynucleotidyl Transferase

the SVCP, 1971-1978

(NOI-CP5-3562)

DNAPolymerase

and Terminal

I I I 1\

I I I \

fontractor's

Prcj~ct

Directoc:

Dr. David Balti~~rc

II ! ! •

Pro~;

Q7ficer

(NCI):

Or. Edward Scolnick

! 1

Objectiv.es: (1) Carry out a detailed analysis of DNApol.vm€ras~~ frai:l 1::-:;:, tumor vir1Js pi:rticlesand from norm~i andneoplastic cells. (Z) Stu~y tp:; mechanism of double-stranded DNA~Yl!thEsis by the cvianmyelobli!sl:os~s \'i;;:~ of Llle t-!1.cynle in ·irff;·.~~':(: ONP.iJolymer;:se and the flJi1cti(jns of t.lir;· s\jbunits cel1s and vi.wiation in DN,u.;Jolymeri1s<:s in various stases of (;dl gru"ii.-; .. Major Findings: Studies of reverse transcription in virions of ~~uLVshowpd . tha t under def i ned cond i t i oos, very long 010 1ecu 1es of comp1ementary D1~P. could be made. These DNA~~lecules were infective in NIH/3i3 cells but actinomycin D blocked synthesis of infective molecules. The longest D:'IF'. made in the presence of actinomycin 0 lacked sequences from the .S'-end of the .viral RNAas shown by heteroduplex ~nalysiswith 21S RNA that was presumably the mRNAfor the glycoprotein of the virion. This RNAWc1S SnOr/f1 to be a composite of 5'- and 3'-proximal sequences. In other studies, it was shown. that reverse transcriptase was made as a 180,(}JD molecular weight precursor that was cleaved in virions to the 85,000 molec\.!1.;r weight reverse transcriptase. The 180,000' protein had antigenicity of both ~ and E£l proteins and was made by a by-pass of UAG codon at the end of the .~gene. This codon could be suppressed in vitro ~Ii:hyeast amber suppressor tRNA but the ~ vi vo mechani srn remai ned unkno~ ' .. Studies of terminal. deoxynucleotidyl transferase'(TdT) continued to definE it as a marker of maturing lymphoid cells probably of both the T and 3.lymphocY":'(1 series. In patients with bli\stic chronic myelogenous 1eukemia, cccurrer,(;c 0" TdT was a very good 1ndicator that remission induction with vincristine and prednisone would be successful. Sianificance to Biomedical Research ~nd the ProGram of the Institu:e: . Fundnmental studies on oncogenic virus repl icatian are nece:;sal'Y to d2fin2 the 1~,,;e of these viruses in rnalignantcell transformation. In vitro synthesis of infectious nucleic acid and in vitro t.ran5lation of p~'oteins al'10\';5 first level mechanistic studies whichcanlogical1y be expected to provide means. for controlling the infections and/or t,ansforming pro:esses. Proposed Co~rse:Analysis of genetic contre! of viral replicativn \'ii11 De analyzed. r1ech~nism of DNAproviral syn:hesi~ by reve,se :rcr.~c:ip:::( :~G the function of RNase H will be explored. 1~ vitro translation ~i11 be used to determine precursor sequences and cleavage·-site5. Date Contract

Initiated:

May 1, 1971

!,


Co 11 trot

POPULLltion

.Fig. 18.9. Pfizer' Contract for "Large-Scale ... ' ,Virus Production for Cancer Research" PFrZER,

INC.

(N01-CP-l·32312

Title:

Large-Scale

Contractor's Project

Project Officer

Objectives: of selec~ed tissue

Tiss,ue

Culture

Director: Ot'.

(NC!):

Virus Or.

Jack

cell

lines,

and

Ca;;cer Research

for

Sami Mayyasi

Gruber

io provide a senice onccgenic and 5uspected

cu1ture

P~'cductiori

fi:cility for the product 6ncogenic viruses, eel

specific

antisera

to

various

oncogenic

Production of these materials is supported by appropriate laboratory whose activitie~ include process i~provement, product standardization, control t~sting, and applied develop~ental research. Major Findings: The current annual rate production results in over·28,OOO liters

of of

'!oll'l,:[;~

en of large; ular antigens,

large-scale tissue vir~S,harvest·fluids

v~r~s::::;, groups quality

culture

and over 1,200 grams of cells being processed to fuHill the needs of 'lOP col1atorat investigators. During the past 12 iTIonths these materials ','/ere distribut2d over 400 shipments to approxi:nately 140 laboratories throughout the world.

The major

viral

products

which accounted endogenous virus feline leukemia

generated

included:

Mason-Pfizer

monkey

type C virus Additionally, Lvon, France,

production, in support s1ides of

produced

supplied

Dur.ing

and this

(MP~V\,

report

(i .e.

li

Gf

of

NC··37 :::13Vif' the tCt~;

but the manipulation and concentr.ation of the .•,:: d<:C:ts amount of time and effort as COp.1pareu to the R;'!f,

prlJduction effort, a disproportionate

..

virui

r.s· i1

for ~pproximately 20% of the contractor's output; baboon (8e'l), 26~; woolly monkey sarCGma virus (55'1-1) lG~; viru~ (FeLV), 17%; RD-ll4 virus, 13~; and Epstein-Barr virus.

Of all viruses produced, more than 50% were gro\'," en human cells lymphoblastoid lir.e, A2C4 rhabdomyosJrccma line). :he prQducti<;~ the P3HR-l and B95-8 cell lines account for only approximately volume requires

.

to

and EBV preparation is a significantacti~ity. Of collaborati'/e studies beir.g concucte:d concentrated P3HR-l cells and RAJI cells IARC

for.EBV

periodamcJjor

epidemiologic

nc\~ effort

c:t t:1~ I'!,::r,

2;~ b!:~i1q

titrations.

vias int.:lud~d

in

the

'riorksccpe.

This inVOlved the production and surply to Program of thr!::e aniwQ1 re~r~vil'uses with spAcia1 characteristics. 1roduction concerr.2d orepdration of highmo1ecu1ar weight RNA-containing BeV, 55'1-1, ilnd Fp-LV for a ~['ecitllly CGlj(Gh:i]:,: coordinated moleCUlar epidemiology study. This labont~ry helped theo"/erall virus production effort and the distribution to the i:(,l1a~0ra.L:~:: research laboratories. ;;., major

effort

:nethodolcgj

\'Ias a1so and

improve

initicted the

qlia1~tj

during

this

of product.

year

to Rol1er

if!Gcerrl :e ·~h2 pl':JductL:1 son e ti~5ue c1j1;.,v::

systems were introduced fnr growth of several of the pr~mate retrOY~rUs2~. gro\,/th orce1ls an 11IiCt'Gc=n-iers lS nO\'! !::::ing sf.'-ioied, ana n<;',', i;ql;i~:r'~n-,; \'Ir:~ purc~'.1sed to mcni~'Jr the sefi3~i;tiol1 of viruses ilr.'j vir::l c:)fi:~o!!Qnt:

:1

conc·:r.:;·at~0r-~ pr1r:~rjut2S. :h~ fe; :::~~; !:2d 1 OUS PC;J':.2C:_ :-:~ f!) r ~:":'~:1;~~IS ::~!"~:::: ~::r-,: >~3 :-;f ~(;~::':~~G '.t.) E~.: ",::: ~ . rc.;?i'l'::~d 0f S~;:;~}!;':::~ ~r(;·:.:·:;~,(-:~ I}:: a ;":.::.~1~ :~: ,:::/~.~.:~::.::-;~~~ s·~J,.i;:;:-.. :.:~ '-.:::~:'.'.~ grcdi~r,'ts

to er.i1a.!;C~ the,

P'.J:~i1Ca.ti(;:!

and

4 I) 7


veatn

m the .7l.ir

Fig. 18.9. Pfizer VII1lS Production Contract Continued A number

of valuable

laboratories human cell

and

origin.

processed

for

be studies.

involved

nature

are

projected

turnor origin for

~iere

and

and

been

as purported,

line

cases

level

froii!ether

were. four

Of these

96 could

\Iere Hela' con~aminant3. ' Activities

for

of

101 individual

purity.

three

same

these

submitted

contamination.

at the

received

among

have

cell

inter-species

to continue

have

distribution;

20 laboratories of species

15%

intra-

of

at CCl

analysis

Of these

others

the

of

remainder

this

of

the

year.

\

Morphologically cells

lines

Approximately

cultures

contract

cell

abnormal

in terms

of

growth

on Narious

growth

studies

.cancer

cell

conditions

lines

pattern,

substrates,

~re

lines for

cell

growth

being

karyology,

in ptogress

to define

of such

compared

'to morphologically

time,

saturation

and, tumofgenicity

on a variety

in an effort

culture

are

cell路 dou~ling

of low

in nude

passage,

the optimum

density,' mice.

nonHela,

n~trition

and

I

norffial

\

clonil

j

Clonal

human envirQnmentai

\

I

cells. \ j

Techniques

for

improved

and

isoenzyme

used

6-phosphogluconic in a variety phoresis

to assay

for

of cell

and

by acrylamide

glucose

dehydrogenase

apparatus

improvement

analysis

6-phosphate

(6PGO),

structures

and

its

subseq~ent

with

utilization

with

Karyologic

characterization

of all

cull~borative

~rograms

requiring

to Biomedical

Research

and

specifiC

culture

media

cells

have

dehydrogenase

!I

been

I

(G6PO),

!

phosphataseisoenzymes

preparative-scale a路view

in the

associated

and

tissue

electrophoresis

alkaline

... A corrmercial

is being ,investigated

various

gel

electro-

to possible

examinatiori

performance'

of

growth

factors

components.

maintained

in the

thE::use

repository

canti:iur:s

kd.'~'yolo~ic.~a'~~.(.;,1:

of

in progress.

~n1i1cance The

contractor

cultures

for

has canser

laboratories, develop

an excellent

and

research the

t~chniques

for

toward

a study

af

between

tumer

cells

Pr~osed

Course.:

the

Date

-158

continu~

Contract

culture to MCI

scientific

and

viruses

Conti nue

to develop

a reference

repository

Initiated:

of

of oncogenic

and

October

ce

11

study tumor

1, 1977

The

is supplying

contract

ef turnor cells cells

ce11

to VO?contract

and

the

c0ntir:u~s oriented interaction

importance.

reagents

laboratory

distribution

tD~~1~~te:

investigators,

and

biology

of

facility,and

community.

the identification fundamental

cai'cinogenesis:continue ~ulture;

studies

general

th~'ProQram

tissue

for

as

substrate.s

karyology

functions.

;-or n~;;;2.:1

of cells

'in

(.:,


'Death m the JLir D ,ID

LITTON

BIONETICS,

Title:

Studies Viruses

Contractor's Project

INC.

(HOI-CP6-1029;

on Molecular

Project

Director:

Officer~:

.Objectives:

Events

Leading

to NOI-CP3-3211)

to Transformation'

Dr. Marvin

Dr. Robert

To characterize

successor

Reitz

Galla

virus-like

particles

in human

with res pect to D~A polymerase and nuc 1e ic aci ds and viral reverse transcriptases from mammalian viruses, C RNA tumor viruses. Major

Findinas:

It was

found

by RNA Oncoger.ic

that

some

human

leukemic

cells

characteri.ze and purify especially primate type

DNA. samples

were

capable

of

forming r.uc1c:ase-resis~ant cornple;.;eswith sii,gle-stl'c1nded nucleic acid pi"obe:: from simian sarcoma virus (SiSV) and murine leukemia virus (MuLV). These complexes

had a thermal

. the presence

within

stability

and

kinetics

the DNA 'samplesof

of formation

a set of DNA

not identical with a portion of the viral genome. found more frequently in leukemic than nonleukemic wj th chronic

sequences endogenous leukemia

myeloyenous

leukemia

was not found rat virus virus

~ith

characterized

Some

in g:-eater detail ~.ge which

p"~~tivc for ••••_1_ ~~ •••••••••

O"~~iotpntly • _,~., ",

G~I

Fresh

hu~an

the

hematopoietic

endooenous

CEo

11 s were

tumorigenic-in .All

these

virus

cells

and w~re were

and SiSV-GalV

Significance

infected

(BaEV) and FeLV.

nude mice

"';"/"'i'i •.••••• ,

""

""_,"

to Biomedical

kn~wledge

acquired

tienship

of viruses

able

acting

Research

1S applied

Date

Course:

Contract

D()cument

.ihis

and

the Procram

in humans,

September

prlWl.'S the dcycll)pmcnl

ui.it~~ ...~\··_H·:..,(r ..

lhi-.'

'P1d ~

L:".... \!)"

tWQ yi~~5~3,

factor .i-bE:_C~ffi2

in semisolid that

medi: .

Epstein-8arr

of the

Institute:

to the development and

The

of the etiological

ultimately,

rela~

of diagnostic to the develop-

June 30, 1978.

1, 1972

of

\Vere UC\:t.'\\)pcd. tc:-;t~..'d :1I1Uthen mass ,\i1~C'.,. (;·,11" \ ~1 .•••••• 1~()\..."J'1 ~ t' .•........•...... '....

SiSV, Ca~'!.

fi~5t

synergistically.

cor-tract terminates

Initiated:

a;iG\'i:'s

to contain

with

of·the

growth

suggesting

to tne determination

to leukemia

appear~d .

to form colonies

and prognostic modalities for human cancer; ment of more effective control measures.

ProDosad

oLadded

animal

"~ru. J ,..[', ,,J :"-•••• . ••••••••••••.••••• i~Q spleen, Y.di''.:j

successfully

In the case

E1~NA-p6sitive,

were

se<;uences, and \'ie:-e

Dr'A.sequenc::s.

ind:Jc!:'d~p gro!{j :1d~5ndgnt

induced

(EBV)

cells were

~ir~5

(FeLV~,

iij::

of gibbon

to a viremic 1

of

viru~

seq~ences.

·and liver, b~t nQ~ the marrow' or other L2~tcd. tissues, an incomD 1ete set of proviral sequences.'

babJon

to but

a normal .plac2ntal

of these

b,'r ..,{"" f""m •..•.•.

recover:::G, ~ias exar.i",n2d~ur GaLV~relat~d

leukemia

strain

including

exposed

~ntib:~rl\l ~. '"'-J)

feline

le'/el of these

for specificty had been

If

type of distributicn

island

had a high

I"tith

related

These sequences W2re DNA samples, p:rt~cular1y

from

DNA samples,

(K562),

line

A nOf,leukemic gibbon

This

probes

(V-/'iRK)and the Hall's

(GaLV-H).

DNA and a CML cell

(C~IL).

labeled

consistent

sequences

mutant \'iru::;~s functional\y produced

Bil)P"!;"S .1 •••• 1_.:

under

'1"r"l'"",'j' \""\",, \..l.-" ••• 1_ ••••.•.

~~:;",;.:!,'~1Llt~1~in~!~.;\ '-:. ~\.~"._",..':

identical

the dirl..,\.,tion t ••..

hl..·r'jr"

\('J ~~~::':'. I.. ":"

\,

.....: .•..

1.11'

It) HIV

:-LCl pr,'jcct ..••. 11.,,,.,11,· _~.~ •.

1,1.: 11

••••

t

l)~~

..

r'.

"' \~


I'

, ~i

'Deatfi

Ifie

ilL

~~ .~. ,~,

/lir

:H~a[lIi

'l'l/vllc

'lJo(i tic.s,

iOIl

(0111

nIl

.~

I

:~(

, INTHE

slll'rnrted

Lea(" plaintiff-appella,its,

helievcs

Appeal No.: 99-4476, (Dist.Ct.

,Ii "

#:98CV2209)

sinccrely

THE FINAL ORDER

Did the di$trict court abuse its discretion

Illl I• ~

ENTERED

ON 10/27/99·

<lraves'

G

SUMMARY

and commit other reversible

errors when it "set aside"

of AIDS bioengineering,

believes

complaint

plaintifT-appellant, relative primarily

ten!.with

and produced 15 yearly progress reports. The archives of ihe National Cancer Institute houses some of the reports. The 'research logic' reveals the program was seeking to isolate, stabilize, develop and proliferate a synthetic'biological agent (a "human" retrovirus). SEE Graves v. Cohne, Exhibit One, filed September 28. 1998. On September 28, 1998, Graves brought suit against the naliled (and yet named) federal defendants pursuant to final proceedings before the of Justice and the little known,

Office of Special Counsel.

J) Graves'

of counsel,

On October 28,

activities

call for no curtailment

~)

Ihcre exists a live controvery

of the excessive

believes process

delay created by the district court's

this malleI' should be immediately and appointment

NATURE On October

retumed

errant judicial

activism.

Graves

to a neutral district court for service of

of counsel.

OF THE CASE

28, I 998,"lhe district court dismissed

as frivolous Graves' claims of AIDS bioengi-

neering against defendant-appellee, U.S. Pentagon, et. al. In order to do so, the district court convenienty"set aside" Graves' Exhibits. Exhibit Onc is page 129 ofU.S. House Resolution

,.f .I

15090, mony Record

Part VI, of the Ninety-First by the U.S. Pentagon is "SYNTHETIC

formedlhe

I

( 4GL.

U.S. Congress

U.S.Co~gress.

Exhibil One is sworn Congressional

given on June 9. 1969. The heading

BIOLOGICAL

AGENT."

of it's invoh'ernent

wonhy

,,1' thrther adilldi~ali,,".

meets nnd exceeds

0,;

June 9. 1969, the U.S. Pentagon

in' the development

testi-

listed in the Congressional of

in-

Graves'

Ihe 'federal rcquirements

motion

for reconsideratioll

!i11'sullkiClley (amended

ulllkl' Fe,'

complail".)

lik.·

,'11

and the substantial.

every otber legitimale

credible scienlifie evidence demand

reqoire an ANSWElt:

of Ihe U.S. Constitution.

I'qually.

c""""

the.l.ktob,·,

\.;.

CONCLUSION

: ~',;. "

.

j, </

The district cOlirt has nbpscd its inherent powers, and has 'aclin:ly' sough I In (h\\ ;If' 1'1 "i't'· elllde this appellant from well established Constitutiona' righls of dne rrncess and elf" d .1\ cess. inter alia. The appellant and the class are bolh enlitled to service of process a,,,1 "" ANSWER. Graves believes the United StDtes should be. compelled 10 ANSWER Ihe ,',,'dihk claims of AIDS bioengineering. ThejudiciDI activism exhibited by thc district coI;rt'is ",ill I" the current "wall of silence" penneating the medica' and scienti fie communities. Th,' "171 . nowchart of this grotesque

federal program

AIDS. The people can now 'easily'

duplicate

is the indi;iJtllable

"missing

link" inlhe cliol, '"~. of

the program's

cxperimellts,

The people c''', ''''''

prove conclusively the AIDS, vims is a chimera. As the :,lIached teller from Senotors n····.\·;,. and Voinovicli indicates (Appcal Exhihil "n," herein. the legislati\'C hraneh of our g('Vl'l'IIIIICI,:

or

injunctive reslriclions, 4) His complaint amI exhibits. filed on September 28, 1998 meet and exceed the federal rules. 5) The district court erred in not allowing service of process. As a direct res lilt of the court's action, Graves' constitutional rights and health continue to sufTer. because

of \l11~

,0 ~

,;

ing of frivolity under 28 USC 1915(e). The district courl's final Order represents an abuse of discretion for a nUlnber of reversible reasoos: 1) There isan identifiable class, 2) Graves has for appointment

Ihal his claim'

sinnal objcc(i~m (0 (he di~(rkt court's dcicrl11ination,~ Gt;l\'CS hclic\:c~ his tin1dy tiled 1I!iI(lpll li" reconsidemlion on 9/27/99. hest exemplifies the IlItality of the sllbslantial c\idenc,' .IC'II,,,t the United Slates. '

1998. the district court dismissed Graves' allegations of AIDS bioengineering as frivolou$ . Graves believes the district court can not "set aside" direct evidence in which to reach a find-

met the standard

"ell"""ll':lIed

1999 pre~s release of Dr. Len lIorowilz'{Appeal Exhibit ",\:' hereill) identilies the I..."I);1JII,I\:'" oflhe National Security Advisory 130ard «(RCI.]Culonel Jack Kingslon as a signilic;""!'I'"t;'·"

Boyd E. Graves ("GRAVES") faces fedto his disability (HIV/AIDS). During the

course of his research into IIIV/AIDS, Graves discovercd a 1971 nowchart, part of an' ultra. sec reI federal program entitled. "Special Virus." The "special virus" began officially in 1962

EEOC, Department

seeret program.

in which to reach a

OF THE APPEAL:

Between 1995 until the present. eral employment discrimination

Ih,' ka"·

NO\'ember 2. 1998, clearly cures ever)' (if allY) defecl identilied hy Ihe district court Oil ('. It'· bel' 28. 1998. The sworn Congressional record. the t10wchart and progress rerort of Ihc "IlL'

APPEAL:.

Grave$' evidence in support of his allegations finding of "frivolity" under 28 USC 1915(e)?

~~ al ~ ( 1'171). l!lIlkr

the .district court is not frce lu set ~'siuc his ('\'ilk-nce of ,·\lDS hiol.·l1!!iI1L'l·rin~,' Ih"

Civ. P. 3(a). Additionally,

QUESTION.ON

l/el'''''

THE COMPLAINT FILED ON SEPTEMBER 28,1998 IS SUFFICIENT FOR SERVICE OF PROCESS

"

(MAJOR)

SEE: Progress

Rnhert C. (lallo. a project o!licer' li,r the prograill. Ih,' "'1"" rctrovi,:tls and cO-1111i,gkd il \\"ilh animal \"irus('s.' (i,:I\I.. ..•

hioengineering arc not fri'volous a",1 ar~ worlhv of an ,\NSWER fromlhe United Slale, ..\\·OIh regard 10 Graves' motion for certitk:tlion of the ciass. ill his' capaeily as kad plaillllll. ",.

"

APPEALFROIH

of the program.

ellj,'in hi'l11Irol11 further filings. Graves has sullieielllly

et. al.. , S. COI-IEN, , ocr endan ts-a ppellees.

WILLIAM

hy the'record

ership of (yet nal11ed) ddcndanl. dnl ,'irus": isol.:ltcd i1 "human"

v.

urlh~ crcdihle hiskH~' l\fthc "~p("d;11 "inls" pfl'!-!r:II11. 11 i:Was well undcm'ay prior .In' 1%1). This I<KI is 111IIr ••,,~hh

a "Spc\:i;tl Virus,"In cl!t1sic.lcratiof1 reasonahk to believe Ihe program

UNitED STATES COU~T OF APPEAL FOR THE SIXTH COURT

BOVD E. GRAVES, et. ,al.•

\,

Popl/lilt

"ff.,;

'ffl;/,

i

alii

"El/jCllics

j,;

\.'1

is indeed spineless with regard 10 any investigalion of the "Special Vims:' Pl'I'haps 11 is "', CaUse NONE of them have AIDS. Please relurn this mallcr immediat~ly to a "fair·",indcol"

J~ "t.} ':.:{'

dislrict court. The people ,",vc a Conslitutional right to ;!ccOlmlahility for the al'pall",~ sla'" conduct of Or. Gallo, Dr. Carlton Gajdusck. Dr. Roberl !\.1anaker. Dr., Paul Kotin. et al'..

Rcspectll,lIv

K'~\" -"

~"-J2<_\, ".

__ '~',

sohmilled. 4<

.,.•.. - -.' '-.....:J .

M,.,_'_

1J,)yd E. Gr:\vcs. pro se

(


~c.6

~WlU ~ /9 ~-ru/}d

j ....

i

IlL !It{~ lit ~, i/o,

Z /1

~

ju~ • i

kr

~/uJ

r.bt/I0J

~C7f~

()( 6t27 / ddoS

// tPuJif.Jlio

IJJ'o·

dozu/

f

levY

tF.Jo

I

i

If· - I

r Z()tA.ltC-

~/crtI!JG£U

-k-t

a~/rIf

~

U7'Ta..r

1

I

1'1 1-7 t-L-

7616

""Id t6f1~ M&ct476

7

c&47L(

/h.!v

170

M

7MrlK'$

(!J~((./j

!

I

I--r--'IIft~ j

fY7'I 11Zv/Vl4

~

'1~

!!/tJII6-r~ J

'/uu

I I IYI&l'/

i~1 j

j

t.f-

tal

jl!tfMoi ! , 1

j

i

~

~

M/

70 1.

IJiL/

71tw1t<v-t6

I/iL

~1/IJ1

70

IrI pit '!aL ~fid

t:.M.Ms fi1t91

!ttillUAf /JM. fa·

1

k

~bt.

l-r~ Jui&6rl 1

/CoWl'

er -la.£. 7Iih6-

;/!ltJ.wdt

/1

I _

jJuCv../1/-rlt',l/-71rl

/11£

7

7/. t-!/

/1'1

Z4r/ !f./J/tI2.T

if

/fIJ1&cf1176

ffJ,t5!-/

t/ldt~

1//.1

/ jt5V

tir(ft;jJ5U/J

1 IfJ

it M ~

Ih.f

MH

'h1Rtc~LLJ

Jvtll

~

/ J

/7 iG 7ic

7: __ /kn ~~ ..;r

Il

1I;()/JI7/~-/

Ne) 70

~.

IJ~

~

(7C'

/Ia,,/-I.-4(

Jh~/T~

7i4r<Y/JUdt7

J bt.1/7'

riR IY'Y tJmc-~ c/

~(jc

1Y/t;(4£.

/f

/ /l£u7'Ht. ;G

/5//1&-1#7[;£1

/1'i1A/71cA 71rr(,

Yd

Jal/IUJ

/Y7 A;{u/V~H1-7icN'

er

jJ I6-drl~.

t#JrI

t5l-o.f.

/11Uq.

/HcL6btfttf tttbft,C.

f{Jl ~//'It..

!ltri/J;~..JJ

7'

/

/AtR7'

{!/HW. Cf'-ta V/iLr "70 Iia£. ~

INIt.L

&;

'(vu

/1'hIf-t.1rl£

Yc.tA

tA.

it:-

MMR/Jlr-t4

/;lfl-lL

/tt£h&tt'UJ.

.

j

J

{//ruJ

YM-

It.

j)/Jao;b

~/tX.4trlU

7("MLJ

/11'/

~crtJ

tj l/'f

~

If#/bclJtfL7tcrl

ut'4,1.u,GJ

ft,L

'

/'I'd


110<:;

f~~~~7f:fi;:-1-::~~:Z~ C..uzu

k

!lU411~ If

kt/t~4

~C7f~

fX

~77-1411d

;# ~.JqJtfX)

C~ I

6Jf9,

ta~

;}cDS

i

j/1.

C-~'·rr~/Cf'.1 I

7 1

er

;i7iofUb-t: /lIV{fJ

7iI1r

:r -rtvT.0JT~ t12uLI

~

klW-rr...JJ

-x:

kltfd1J ~

~

III

0

{CI'llltJ£.R.Ir-{(",.

J}1y

IrlMJr//,/J r"", (f/'IJ(j7j C/

1b./6&r1c£

$CtI'J6-t7

1;,fOC/.AfC TJit

Ilri ;JIJIYI/rIIJTM7Iu! ,ltUe£

7y/Jp·ttr ,tJr;£!

/Y<J!"

1tUcl.

"I /110

/ZALc7

eN

~

IrlW71h17tw.

7ltC

{o-C/h.M71w

I~

JUI.7 w£ ~ ~

1~/JtUJ I

!IJIJt1414-1

~,£ Lt.

{r T 7

(;~

17 Jrlt'Ro~«-

~1

IkfJUM'£

KtrdJ

lYI/11tYlI

j)..//.-tJc #/dJ aJ4t

~

~1'<r(<"

£lJtL~ 1/;1I

er

i j)~4iTA¥.-vI7

iwl'Ju

{/~I

7l£ kCEvi

!~fH~ vc

L-

Lu

71

Cl,

1J..k,.u& h.Low""c..

W!"

~

hd.(/~

eR I/YT4-(7) 7URcu#

~J

<t'

Ja/<Mi

.rW?~7

:4;Loc:,5dtc

~

('RMtZ,c-lZO

/jbc..,{.fj

k7IcA7~I.: fkifl71t/1/7 tr ~(H

er

4.[ OC

~7J:

a{ur(f

j k7' ;'

Z7f/I 1f~77'

pi,?,

;I

alt-Hi

~/r/lrtLJdiJt.{

M

/rli-6j7iM-7EvY

"I


JL Ilob £7fvvI

kLbt471V'41t.. IMtL~71M1..

7t:r1iJY'V'l7.

I~C41Zu-1 /JlJcW'J

0) ----

U

t:udJ

~

M71V?'t4t

.ku

Co

fJJ

.

wltLt"'h

70

'td

Cl

7:.71/ /

/i;;t

LIlY

k.ir7/17tt-C

tf.

fvOM7

IlhW&liY

r ~~.:cr

.

76

L7~

I/tf t:J4t;a. 76

k-J

~OLaZ1-

~

.&c£LJ .'

'" // Hv~

10

.& ~

jJ/U;j~ ~6'

/

k-H'

·T~

~

~../(4t.~

1~;Jr/7' ~

lr{tlSJrl'~7t~ I

I~

d.

~

C(/V7'4c?'

C(/YH?17~7

~/WY'

,tbCtAH.d?;97lW

~

~

U#l"'WI C//71r/'{f

Jiyl/l/~

CC/'//4;7

IHM;YiH7iV"/

You

&ol45J?"

r

~

fo

~,f

!Zt:Ju/.t<7trl ~

7J.£.

~U?O

I{g

y C~/7'

Id/tAL JuPfJtIl7

7dRot./#

.If£!

/Yh'J-I.7

,/

~

If; J,. ~ ,

t~

~

~~

t';i,l/-d

/7 M7 .& Jd/tJUf.t1

I/w.JC,/N£

.

7&' ~

/Of

dZ-4-N

r

CtlILt4rl

47fKuz.

~JWi..

{}/RcL

(}#icL.

Y<-~

//14

"

j

tT~ Lt M r

7V£

o1~

/J 70 'taL If &out,&L) c;C ~

w-r/£M-7ltJrV

{(j - oO.[.tA7tr/'-l

U

I b1f4tf jt!M,f

~

;1.Af,l. tJ/7II/AJL/.J

#cJ~

J

11

/J

/JIW7u.e

/?vt1

!l--1/r/owr7if/V

7b

J47fJ/l1c71r.rl_

f'~

;c6/..L..

it1

$iECI4NU .

;

/v.£

L/~ ~

/f'Y

;l/(A;t~~-J~ 70

~

.z

C4l'C&,elua.7

Zza.r MW7:

j

i

Ik-··

t J,;rRoU-/tc t Zt/(){,.I<'..Atc-

,tJ aUriS 44J

ky

(Jb~VY1 ~1,

Il"

1J41'€LJ

;1h,tl.)

d1

k

16 de..

OtvS

rltrJ.l ~

N

vJIJ/~

(J)

kri ~~ I)


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.